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The highly conserved histone chaperone FACT (Facilitates Chromatin 
Transcription) is thought to contribute to the disassembly and reassembly of 
nucleosomes in the wake of RNA polymerase II passage through chromatin. In yeast, 
mutation of FACT subunits leads to decreased nucleosome occupancy at the promoters 
and transcribed regions of genes. In addition, genetic experiments suggest that yeast 
FACT plays a critical role in restricting initiation of transcription to promoters, ensuring 
that only appropriate mRNAs are synthesized.  
However, FACT’s roles in chromatin biology and transcriptional regulation in 
higher eukaryotes are not well understood. Using Drosophila S2 cells as a model, I 
observe that depleting levels of the FACT complex results in aberrant transcriptional 
regulation of approximately 20% of expressed genes. We hypothesized that FACT-
dependent alterations in transcription occur because nucleosome disassembly and 
reassembly are defective in FACT deficient S2 cells. To address that hypothesis, I 
monitored the nucleosome positioning using genome-wide micrococcal nuclease 
protection assays, and the distribution of bulk histones, histone variants, and histone 
modifications using ChIP-seq. I observed that FACT depletion has little effect on total 
nucleosome occupancy or positioning or on the distribution of either the histone variant 
H2Av or the histone 3 lysine 56 acetylation (H3K56ac) mark. On the other hand, the loss 
of FACT alters the distribution of other histone modifications, including histone 3 lysine 4 
trimethylation (H3K4me3) and histone 3 lysine 36 trimethylation (H3K36me3), in the 
promoters and transcribed regions of genes. In particular, H3K4me3, a mark of active 
promoters, was reduced at promoters and increased in gene bodies of the FACT depleted 
cells. Furthermore, levels of H3K36me3, a mark of active transcription over transcribed 
regions, was reduced in gene bodies but increased beyond the polyadenylation site. The 
levels of total (Rpb3) and transcriptionally engaged Pol II (PRO-seq) were reduced at 
promoters upon the loss of FACT.  
Taken together, our results are consistent with the model that FACT contributes to 
the interplay between chromatin architecture and control of promoter-proximal pausing. 
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1.1 Chromatin and gene regulation 
The term “chromatin” was initially coined by W. Flemming to describe the 
substance in the cell nucleus that is refractile in nature and can be readily stained 
(Flemming, 1882). By the beginning of 1970s, more progress had been made to 
understand the chromatin structure. At that time, evidence suggested that histones 
reduce RNA transcription significantly (Allfrey et al., 1964), but not much was known 
about the nature or relative amounts of individual histone proteins. In 1967 E. W. Johns 
used polyacrylamide gel electrophoresis to quantify the five major histone fractions, f1, 
f2(a)1, f2(a)2, f2(b) and f3 prepared from calf thymus (Johns, 1967). These "fractions" are 
now known as histones H1/H5, H2A, H2B, H3, and H4 respectively.  
Work by Hewish and Burgoyne provided evidence for the existence of a repeating 
chromatin sub-structure with regularly distributed sites that can be cleaved by 
magnesium- and calcium-dependent endonuclease. They observed a non-random ladder 
of DNA after digestion of rat liver chromatin by a nuclear calcium and magnesium 
dependent endonuclease. Based on this result they proposed that, “chromatin has some 
simple, basic, repeating substructure with a repetitive spacing of sites that are potentially 
accessible to the Ca-Mg endonuclease” (Hewish and Burgoyne, 1973). 
To study the structure of chromatin, Olins and Olins visualized chromatin isolated 
from fresh rat thymus, rat liver, and chicken erythrocytes using electron microscopy. The 
micrographs they obtained show that chromatin fibers appear as “particles on a string” 
(Olins and Olins, 1974). A similar observation was made by Woodcock and colleagues in 
micrographs of chromatin isolated from a wide range of tissues including chicken 
2 
 
erythrocytes, amphibian erythrocytes, chlamydomonas and fruit fly salivary glands. These 
observations led them to hypothesize that the “spherical particles are a fundamental 
structural unit of chromatin”(Woodcock et al., 1976). 
Based on results from biochemical and x-ray diffraction experiments, Kornberg 
and Thomas proposed that the chromatin structure is composed of repeating units of 
eight histones consisting of a histone H3-histone H4 tetramer, dimers or oligomers of 
histones H2A andH2B, and about 200 bp DNA (Kornberg, 1974; Kornberg and Thomas, 
1974). Evidence for the proposed tetramer came from cross-linking and sedimentation 
experiments followed by electron microscopy. 
Oudet and colleagues were the first to introduce the term “nucleosome” to 
describe the particles that aligned along the chromatin fiber. They chose the term 
nucleosome because of the nuclear origin of the particle and its similarity to the “nu” (ν)-
bodies described by Olins and Olins. Based on biochemical and electron microscopic 
examination, Oudet and colleagues showed that “ the fundamental structure of 
chromatin fibers is composed of a flexible chain of spherical particles with a diameter of 
124-130 Å connected by DNA filaments,” consistent with Kornberg’s model of the 
nucleosome structure (Oudet et al., 1975).    
In addition, Finch and colleagues prepared nuclei from rat liver and subjected the 
chromatin to micrococcal nuclease digest. They then visualized the nucleosome core 
particle crystals using X-ray diffraction and electron microscopy. They observed that the 
core particle is flat with dimensions of about 110 x 110 x 57 Å, and they proposed it is 
divided into two layers with 1 ¾ super helical turns of DNA on the histone octamer (Finch 
et al., 1977). In order to have a better resolution of the electron density map of the core 
particle from 20 Å, Richmond and colleagues improved the preparation of the histone 
core crystals. They then solved the nucleosome core particle to a 7 Å resolution 
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(Richmond et al., 1984) which confirmed the dyad . The resolution of the nucleosome 
core particle was further improved by Luger and colleagues to 2.8 Å (Luger et al., 1997) 
and later refined to 1.9 Å (Richmond and Davey, 2003). 
The current and prevailing model is that, in eukaryotic cells, DNA is tightly 
packaged into nucleosomes to form chromatin. Nucleosomes therefore form the basic 
repeating unit of the chromatin consisting of a histone octamer with 146 bp DNA wound 
1.65 times around H3-H4 tetramer and two H2A-H2B dimers. Linker DNA of variable 
lengths connects the nucleosomes. 
1.1.1 Histone modifications  
In the 1960s, Allfrey and colleagues presented a groundbreaking observation 
suggesting roles of histones and histone modifications (acetylation and methylation) in 
transcription regulation. After being inspired by work from Stedman and Stedman, Allfrey 
and colleagues initially demonstrated that "histones inhibit RNA synthesis in isolated 
thymus nuclei” and that “removal of the histones from the nucleus results in an increased 
rate of messenger RNA synthesis” (Allfrey et al., 1964). Allfrey and colleagues further 
showed that methylating and acetylating histones relieves inhibition of RNA polymerase 
activity (Allfrey et al., 1964).  
Today, there are vast array of enzymes identified capable of modifying certain 
residues on the globular core domains and histone tails. For example, the lysine residues 
on histone tails can be acetylated, SUMOylated, ubiquitinated, biotinylated and 
methylated. Arginine residues on histone tails can be methylated, citrullinated and 
ribosylated. Likewise, glutamic residues can undergo ADP-ribosylation. Serine and 
threonine residues can be phosphorylated. Proline residues can be isomerized. More 
recent evidence suggest that most of these modifications have biological implications 
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(Latham and Dent, 2007). For the purpose of this thesis, I will focus on histone 
modifications related to transcription.  
1.1.1.1 H3K36me3 
The lysine residue 36 on H3 tails can be mono- , di- , and tri-methylated, by a wide 
range of methyltransferases. Current literature describes at least 8 enzymes, all bearing a 
SET domain capable of methylating H3K36 in mammals (Wagner and Carpenter, 2012). 
The methylated lysine residues can also be enzymatically de-methylated depending on 
the need of the cell (Black et al., 2012). 
Histone methyl transferases methylate the lysine residues on H3 by utilizing S-
adenosylmethionine. Set2 was initially identified in yeast as a histone methyl transferase 
that mediates tri-methylation of lysine 36 of the histone H3 tail (Strahl et al., 2002). 
Genome-wide data obtained from ChIP of H3K36me3 coupled with DNA microarray 
suggests (i) that H3K36me3 occupies gene bodies, with a bias towards 3’ends of open 
reading frames and (ii) that it correlates with transcriptional activity (Pokholok et al., 
2005).  
Studies from the Workman lab and others have shown that the presence of 
H3K36me3 across gene bodies recruits Rpd3S deacetylase, which removes acetyl residues 
across gene bodies rendering them in a hypo-acetylated state thereby preventing cryptic 
transcription (Carrozza et al., 2005). Biochemical and genetic experiments reveal that the 
H3K36me3 methyltransferase Set2 interacts with Ser2 phosphorylated Pol II through the 
Set2 WW domain and plays a role in transcription elongation (Li et al., 2002). The model is 
therefore that Set2 is recruited to Ser2 phosphorylated Pol II and that it methylates 
histone tails during transcription elongation.  
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The highly conserved JmJC domains of the lysine demethylases KDM4A, KDM4B, 
KDM4C and KDM4D mediate the demethylation of H3K36me3 by utilizing α-ketoglutarate 
in the presence of the cofactors Fe (II) and oxygen (Black et al., 2012; Shi and Whetstine, 
2007). 
Results of co-immunoprecipitation experiments performed in SETD2-depleted 
cells suggests H3K36me3 recruits the histone chaperone and elongation factor FACT to 
transcribed regions (Carvalho et al., 2013). Based on this observation, it has been 
proposed that Set2 regulates recruitment of FACT through H3K36me3. 
1.1.1.2 H3K4me3 
The highly conserved histone H3 tail residue lysine 4 can also undergo post-
translational modifications. H3K4 can be mono-, di-, and tri-methylated by a collection of 
histone methyl transferases. Depending on the needs of the cell, methylation on lysine 4 
residue of histone H3 tails can be reversed by histone demethylases.  
Genome-wide mapping of H3K4me3 using chromatin immunoprecipitation 
followed by DNA microarray suggests that histone H3 lysine 4 tri-methylation is enriched 
at promoter regions of active genes (Pokholok et al., 2005). In addition, Pokholok and 
colleagues observed that levels of H3K4me3 occupancy correlate with transcriptional 
activity. Quite recent work using genomics suggests that the broadening of H3K4me3 into 
gene bodies is strongly associated with transcription elongation (Chen et al., 2015b).  
Tri-methylation of H3K4 is carried out by the Set1/COMPASS, a highly conserved 
protein complex from yeast to humans (Briggs et al., 2001; Noma and Grewal, 2002; 
Shilatifard, 2012). H3K4me3 methylase Set1 has been shown to be associated with the 5’ 
end of genes and interacts with Pol II phosphorylated on Ser5 of the Rpb1 CTD but not Pol 
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II phosphorylated on CTD Ser2 residues (Ng et al., 2003). KDM5A, KDM5B, KDM5C and 
KDM5D demethylates tri-methylated H3K4 (Black et al., 2012).  
Stanlie and colleagues demonstrated connections between FACT and H3K4me3 in 
in experiments where levels of FACT were manipulated followed by ChIP-qPCR of 
H3K4me3. They observed that the reduction of FACT levels leads to a reduction of 
H3K4me3 levels over immunoglobulin µ and α heavy chain switch regions (Sµ and Sα, 
respectively), suggesting that FACT-dependent changes in H3K4me3 plays a role in Ig class 
switch recombination (Stanlie et al., 2010). 
1.1.1.3 H3K56ac  
H3 lysine 56 acetylation is one of the few modifications that occurs on the globular 
core domains of histones. Efforts from a number of researchers have demonstrated that 
H3K56 acetylation is well conserved from yeast to humans (Das et al., 2009; Ozdemir et 
al., 2005; Yuan et al., 2009). In yeast, H3K56 acetylation mostly marks newly synthesized 
histone H3 (Masumoto et al., 2005). Also, H3K56 acetylation increases during S-phase of 
the cell cycle. (Masumoto et al., 2005; Recht et al., 2006). Acetylation of lysine 56 also 
functions to maintain genome integrity (Yuan et al., 2009). In order to maintain an 
optimal pool of H3K56 acetylation in the cell, histone methyl transferases and 
deacetylases play an instrumental role regulating H3K56ac homeostasis. The yeast H3K56 
acetyl transferase, Rtt109, was discovered after a collection of 4700 yeast mutants were 
screened for H3K56 acetylation using specific antibodies (Han et al., 2007). Orthologues 
of the H3K56 acetyl transferase, CBP and CBP/p300 have been found in Drosophila and 
humans respectively. On the other hand, yeast Hst3 and Hst4, Drosophila Sir2, human 
SIRT1 and SIRT2 mediate the deacetylation of H3K56ac (Celic et al., 2006; Das et al., 2009; 
Maas et al., 2006). Genome-wide data obtained from the ChIP of H3K56ac followed by 
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microarray analysis suggests, H3K56ac occupies predominantly promoters of active genes 
(Rufiange et al., 2007).  
1.1.1.4 H2A.Z 
H2A.Z is a histone 2A variant that is evolutionarily conserved from yeast to 
humans (Iouzalen et al., 1996). The H2A.Z amino acid sequence is about 60% identical to 
the canonical H2A histone (Jackson et al., 1996). Similar to histone H2A, H2A.Z can 
undergo a number of post-translational modifications including acetylation, methylation, 
ubiquitination and SUMOylation (Sevilla and Binda, 2014).  
Histone H2A.Z has been shown by a number of labs to be essential for survival. Mutations 
in H2A.Z are lethal in a wide range of organisms including the fly, frog, mouse, and 
tetrahymena but are not lethal in yeast (Bonisch and Hake, 2012). However mutations in 
yeast H2A.Z result in slow growth (Jackson and Gorovsky, 2000). 
Genome-wide experiments have shown that H2A.Z is preferentially enriched at 
promoters of genes from yeast to humans (Guillemette et al., 2005). H2A.Z is associated 
with both active and inactive genes depending on the organism. In yeast, H2A.Z 
occupancy at promoters is poorly correlated with transcriptional activity (Raisner et al., 
2005). In contrast, Barski and colleagues showed using data from ChIP-seq of H2A.Z in 
human CD4+ T cells that H2A.Z occupancy correlates with level of gene expression (Barski 
et al., 2007). The yeast SWR1 complex, a member of the Swi2/Snf2 family of ATPases, was 
the first enzyme demonstrated to mediate the exchange of histone H2A-H2B dimers for 
H2A.Z-H2B dimers in an ATP-dependent manner (Krogan et al., 2003; Mizuguchi et al., 
2004). Tip60, the Drosophila homologue of the Swrc-1 complex, mediates the deposition 
of H2Av (Kusch et al., 2004). INO80 on the other hand mediates the eviction of H2A.Z in 
an ATP dependent manner (Papamichos-Chronakis et al., 2011).  
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Recently, Jeronimo and colleagues have demonstrated that FACT mutations are 
associated with mislocalisation of H2A.Z into gene bodies in yeast and an increase in 
cryptic transcription (Jeronimo et al., 2015). Based on this observation, they proposed 
that the presence of H2A.Z within genic locations results in a less stable nucleosome 
leading to cryptic transcription.  
1.2 Histone chaperones 
Transcription, the making of RNA by RNA polymerase using a template DNA, 
occurs in a chromatin context in vivo. Transcription in vitro has been shown to be limited 
by the presence of nucleosomes. Nucleosomes therefore act as barriers that deny access 
to transcription factors and other transcription machinery and, as a consequence, play a 
major role in regulating gene expression. Cells have therefore evolved a collection of 
enzymes, examples of which are histone chaperones, that help alleviate the inhibitory 
role of nucleosome to allow transcription initiation and elongation. 
In 1978, R. Laskey and colleagues coined the term ‘molecular chaperone’ to 
describe the activity of a chromatin assembly factor in Xenopus egg homogenate that 
prevents mixtures of DNA and histone from precipitating under physiological ionic 
strength (Laskey et al., 1978; Laskey et al., 1977). Further characterization of the 
chaperone reveal that it prevents inappropriate ionic interactions between DNA and 
histones. Histone chaperones, as they are currently termed, are defined as a family of 
proteins that bind histones and mediate one or more of the following processes; 
transport, storage, assembling, and disassembling of histones. Histone chaperones can 
have redundant and specific roles. Histone chaperones can bind preferentially to H2A-
H2B histones, H3-H4 histones, or histone variants (Burgess and Zhang, 2013). 
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Histone chaperones are involved in distinct steps in the assembling of 
nucleosomes. First, after histone proteins are synthesized in the cytosol, they are 
imported into the nucleus. Some histone chaperones, such as Nap1, help to shuttle newly 
synthesized histones from the cytoplasm to the nucleus in part through regulation of the 
importin-histone interaction. Second, a soluble pool of histones must be maintained to 
meet challenges during stress conditions and histone chaperones such as NASP act as 
reservoirs to maintain histone supply. Third, some histone chaperones and histone-
binding proteins, such as RbAp46 and Asf1, directly regulate the enzymatic activity of 
histone-modifying enzymes. Fourth, other histone chaperones are thought to be directly 
involved in the eviction and deposition of histones during transcription or replication. 
1.2.1 FACT complex 
1.2.1.1 Discovery of FACT 
The FACT complex is evolutionarily conserved from yeast to humans. FACT was 
discovered as CP complex (Cdc68 and Pob3) and SPN (Spt16, Pob3, and Nhp6) in yeast, 
DUF (DNA unwinding factor) in Xenopus, and FACT (facilitates chromatin transactions, 
composed of SPT16 and SSRP1) in humans. It is therefore not surprising that FACT is 
implicated in transcription, replication and DNA repair pathway. 
The yeast Spt16 (Suppressor of Ty insertion) was identified through yeast genetics 
as a high-copy-number suppressor of δ insertion mutations in the 5’ regions of the HIS4 
and LYS2 genes of S. cerevisiae (Clark-Adams et al., 1988). Through genetic mapping and 
complementation analysis it was demonstrated that SPT16 is identical to CDC68 (cell 
division cycle) (Malone et al., 1991). Further characterization showed yeast Spt16 is 
important for growth and plays a role in transcription regulation (Malone et al., 1991). 
Brewster and colleagues discovered through purification that Cdc68 exists as a 
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heterodimer with Pob3, which they termed the CP complex (Brewster et al., 1998). Prior 
to the discovery of the CP complex, work from Wittmeyer and colleagues had 
demonstrated that the yeast DNA polymerase 1 (DNA Pol 1) protein interacts with 
Cdc68/Spt16 and Pob3 (Wittmeyer and Formosa, 1997), implicating yeast FACT in DNA 
replication.  
SSRP1 (in Xenopus known as DUF87) is the metazoan orthologue of yeast Pob3. 
SSRP1 has a highly conserved HMG1 motif that confers DNA binding ability. For this 
reason, Formosa and colleagues (2001) considered the possibility that an HMG1 
containing protein might interact with the yeast CP complex. Through genetic screening, 
the HMG1 containing protein Nhp6 was found to display a strong interaction with the CP 
complex. Purified Nhp6 is capable of binding to nucleosomes, and Spt16-Pob3 binds to 
Nhp6-bound nucleosomes. Based on this observation, Formosa and colleagues proposed 
that Nhp6 provides a "landing pad" for Spt16-Pob3 on nucleosomes. Binding to 
nucleosomes of Spt16-Pob3 and Nhp6 (collectively referred to as the SPN complex) can 
result in nucleosome remodeling (Formosa et al., 2001). 
Human FACT was identified in Reinberg’s lab as an activity that stimulates 
transcription elongation over chromatinized template in vitro (Orphanides et al., 1998). 
The FACT activity copurified with polypeptides that migrate at 140 (p140) and 80 kDa 
(p80) on a PAGE gel. Determination of p80's sequence revealed that it is identical to a 
protein that had been identified as SSRP1 (Orphanides et al., 1999). SSRP1 was initially 
discovered during a search for cellular factors that can process DNA modified by the 
highly potent antitumor drug, cis-diamminedichloroplatinum or cisplatin (Toney et al., 
1989), which has been shown to disrupt DNA replication and transcription by altering the 
structure of the DNA. Further characterization of the structure of SSRP1 led to the 
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discovery that it includes peptide sequences similar to HMG box 1 and 2 proteins (Bruhn 
et al., 1992). 
Drosophila FACT, also known as dFACT, is a heterodimer of dSpt16/Dre4 and 
dSSRP1. dFACT was identified through a purification to identify GAGA factor associated 
proteins. Anti-flag purification performed with nuclear extracts prepared from embryos of 
transgenic flies expressing Flag-tagged GAGA factor identified two proteins on the stained 
SDS-PAGE gel in addition to GAGA factor. Peptide sequencing followed by western 
blotting showed that these proteins were dSpt16 and dSSRP1. Drosophila FACT has been 
shown to modulate chromatin structure in vitro and to function with GAGA factor in 
regulation of Hox gene expression (Shimojima et al., 2003).  
Okuhara and colleagues used old fashioned chromatography to purify DUF (DNA 
unwinding factor) from Xenopus egg extract as an activity that introduces negative 
supercoils into a relaxed duplex DNA in the presence of topoisomerase I. Okuhara and 
colleagues monitored the activities of eluate fractions from the six successive column 
purification of Xenopus egg extract capable of introducing negative supercoils into duplex 
DNA in the presence of topoisomerase I. The DNA unwinding activity migrated at 140 kDa 
and 87 kDa and eluted as a single band (250 kDa) through gel filtration chromatography. 
Peptide sequencing followed by sequence analysis of the DUF-encoding cDNAs showed 
that DUF140 and DUF87 are homologous to yeast Cdc68/Spt16 and human SSRP1 
respectively. In this same study, DUF was found to play a major role in DNA replication. 
Immunodepletion of DUF from Xenopus extracts using anti-DUF140 antibodies reduced 
their ability to replicate added sperm chromatin to 5- 25%. In contrast, DNA replication 
was restored to about 75% of the control when purified DUF was added back to the 
reaction (Okuhara et al., 1999). 
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1.2.1.2 Structural insights 
In metazoans, the FACT complex is a heterodimeric protein complex consisting of 
Spt16 (Suppressor of Ty 16) subunit and SSRP1 (Structure specific recognition protein 1) 
with molecular weights of ~140 kDa and ~80 kDa respectively (Orphanides et al., 1999). 
However, the yeast analogue of the SSRP1 subunit is a complex consisting of Pob3 (Pol I-
binding protein 3) and Nhp6 (Non-histone protein 6) (Brewster et al., 2001; Formosa et 
al., 2001).  
Work from a number of labs has defined structural domains of the FACT complex. 
The Spt16 subunit is composed of the N-terminal domain (NTD), the dimerization domain 
(DD), the middle domain (MD) and the C-terminal domain (CTD) (Keller and Lu, 2002; 
O'Donnell et al., 2004; VanDemark et al., 2006).  
O’Donnell and colleagues demonstrated that the Spt16 NTD is well conserved and 
not essential for yeast viability. Purification of the Spt16NTD followed by crystallization 
showed that the Spt16 NTD has two lobes with the C-terminus lobe folded like “pita 
bread” and structurally looks like amino-peptidases (VanDemark et al., 2008). Using gel 
filtration and GST-pulldown assays Ladurner’s lab showed that Spt16N interacts with the 
globular domains and tails of H3-H4 histones (Stuwe et al., 2008).  
The Spt16 subunit of FACT dimerizes with SSRP1/Pob3 through the Spt16DD and 
SSRP1DD dimerization domains (Keller and Lu, 2002). Hondele and colleagues purified, 
crystalized and solved the structure of the dimerization domains of yeast FACT (yFACT: 
Spt16D-Pob3N). They observed that Sp16D contains a single pleckstrin homology-like 
(PHL) module and Pob3 contains tandem PHL modules with the second module lacking 
the capping helix. The yFACT dimerization domains does not interact with H2A-H2B 
histones nor H3-H4 but co-precipitates with the large subunit of DNA polymerase α. 
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The Spt16 middle domain (Spt16M) is evolutionarily conserved and it is composed 
of a tandem pleckstrin homology-like (PHL) modules (Kemble et al., 2013). Kemble and 
colleagues observed, using EMSA, that Spt16M contacts H3-H4 histones with low affinity 
and that the Spt16M domain does not contribute significantly to the binding of Spt16-
Pob3 to H2A-H2B. Quite recent work by Hondele and colleagues using crystals of the 
Spt16 middle domain (Spt16M) purified from Chaetomium thermophilum reported that 
Sp16M interacts with a higher affinity with H2A-H2B than with H3-H4 (Hondele et al., 
2013). An alternative report from Kemble and colleagues determined that the acidic 
Spt16CTD tails mediate the interaction between FACT and H2A-H2B rather than the 
middle domain (Kemble et al., 2015). 
The Spt16 CTD is highly acidic and it interacts with nucleosomes and stimulates 
transcription elongation. Mutations of FACT bearing a Spt16 CTD deletion cannot 
assemble nucleosomes and does not stimulate transcription elongation (Belotserkovskaya 
et al., 2003).  
The metazoan SSRP1 subunit of FACT is composed of an N-terminal domain (NTD), 
dimerization domain (DD), and middle domain (MD), as well as two intrinsically 
disordered regions flanking an high-mobility group HMG-1 domain (Tsunaka et al., 2009; 
VanDemark et al., 2006).  
The roles of SSRP1 domains in nucleosome assembly and disassembly are not fully 
understood. Reinberg’s lab demonstrated using biochemical assays that full length 
recombinant hSSRP1 binds to histone H3-H4 tetramers. In addition, SSRP1 HMG-1 domain 
mediates FACT binding to DNA in a non-sequence specific manner to enable effective 
disassembly and reassembly of chromatin (Masse et al., 2002). Apart from the SSRP1 
HMG-1 domain, SSRP1-M is capable of binding to dsDNA. Zhang and colleagues obtained 
crystal structure of the SSRP1 middle domain at a 1.93 Å resolution. The structure 
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contains tandem pleckstrin homology domains and is positively charged on each side. 
They discovered through pulldown and gel filtration assays that SSRP1-M binds non-
specifically to DNA but binds weakly, if at all, to histones (Zhang et al., 2015). 
1.2.1.3 How FACT reorganizes the nucleosome 
There are currently a number of models describing how FACT 
displaces/reorganizes nucleosomes to allow the transcription machinery to gain access to 
the underlying sequences in cells. 
Reinberg’s lab proposed the dimer displacement model based on observations 
that suggest that hFACT removes either one or both of the H2A-H2B dimers to allow RNA 
Pol II passage (Belotserkovskaya et al., 2003; Orphanides et al., 1999). Reinberg’s lab 
observed that the hSpt16 and SSRP1 subunits bind H2A-H2B dimers and H3-H4 tetramers 
respectively. Also, incubating purified hFACT with an immobilized chromatinized template 
leads to loss of about half of H2A-H2B dimers from nucleosomes. In addition, FACT 
mediated transcription through chromatinized templates leads to the formation of a 
hexasome.   
The nucleosome reorganization/ nucleosome breathing model (Hondele et al., 
2013; Kemble et al., 2015; Xin et al., 2009) was initially proposed by Xin and colleagues 
who provided evidence that yFACT reorganizes nucleosomes into a looser and more 
dynamic form with the original histone composition. Structural work from Hondele and 
colleagues also supported this model with results that showed that the middle domain of 
Spt16 makes several contacts with histones and gradually disrupts H2A-H2B-DNA 
interaction enhancing “nucleosome breathing” (Hondele et al., 2013).  More recent 
structural and biochemical work by Kemble and colleagues suggest that “FACT maintains 
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nucleosomes in an altered, loosened structure at least in part by competing with DNA for 
binding both H2A-H2B dimers in a nucleosome” (Kemble et al., 2015). 
1.2.1.4 Role of FACT in transcription regulation 
A variety of evidence supports FACT's role in regulating RNA transcription. As 
noted earlier, human FACT was initially identified and purified using biochemical methods 
as an activity that stimulates transcription elongation over chromatinized template in 
vitro (Orphanides et al., 1998). Mutations in genes that encode transcription elongation 
factors in yeast often cause growth defects in the presence of 6-azauracil (6-AU) (Powell 
and Reines, 1996). FACT was implicated in transcription elongation after yeast Spt16 
mutants showed growth defects in the presence of 6-AU (Formosa et al., 2001; John et 
al., 2000; Orphanides et al., 1999). In addition, the observation that Spt16 interacts 
genetically and physically with elongation factors such as Paf1 complex members, TFIIS 
and Spt4 subunit of the Spt4/5 complex, further implicates FACTs in transcription 
elongation (Orphanides et al., 1999; Squazzo et al., 2002). Immunofluorescence staining 
of FACT and elongating RNA polymerase II on Drosophila polytene chromosome shows 
they colocalize at active sites (Saunders et al., 2003).  
Crosslinking followed by ChIP-qPCR of FACT on active Pol II genes showed yeast 
FACT occupies transcribed regions (Mason and Struhl, 2003). In this experiment, Mason 
and Struhl showed that FACT is enriched on a number of active Pol II transcribed genes. 
Work from Ransom and colleagues demonstrated using yeast genetics and biochemistry 
that yFACT is involved in the disassembly of histone H2A/H2B from the PHO5 promoter to 
activate transcription, implicating FACT in transcription initiation (Ransom et al., 2009). 
In addition, conditional inactivation of Spt16 in yeast results in decreased binding 
of TBP and TFIIB, components of the Pol II pre-initiation complex, at normal promoters 
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(Mason and Struhl, 2003), suggesting that FACT is necessary for TBP and TFIIB occupancy 
at promoters. On the other hand, mutations in yeast Spt16 result in transcription from 
cryptic promoters within the coding regions of some genes. This suggests that FACT plays 
a role in preventing inappropriate transcription initiations from promoter-like regions in 
cells (Kaplan et al., 2003; Mason and Struhl, 2003). In addition, in vitro studies show that 
Spt16 can mediate TBP binding to promoters (Biswas et al., 2005). These observations 
point to the role of FACT not only in transcription elongation but also in transcription 
initiation.  
In a minimal transcription system, FACT can inhibit basal transcription of a 
supercoiled DNA template. On the other hand FACT, in concert with PTEFb, can promote 
transcription over naked DNA which was otherwise inhibited by NELF and DSIF (Wada et 
al., 2000). 
In the quest to understand whether the role of FACT in transcription regulation is 
global or only specific to some genes, Li and colleagues purified RNA from human non-
small cell lung carcinoma (H1299) cells depleted of either SSRP1 or Spt16 followed by 
spotted microarray analysis. The microarray data revealed that only ~1.3% of the 8308 
genes tested were either up-, or down-regulated following the knockdown of SSRP1 and 
Spt16. In addition, Spt16 and SSRP1 regulate the expression of a common and unique sets 
of genes (Li et al., 2007). Thus the FACT complex does not only promote transcription 
elongation as it was originally discovered but also represses the expression of genes. 
1.2.1.5 FACT’s role in cancer 
Over the years, the expression of FACT has been linked to a number of cancers 
including ovarian cancer, colon carcinoma, melanoma, pancreatic ductal adenocarcinoma, 
glioblastoma, hepatocellular carcinoma and neuroblastoma. Initial speculations of the 
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possible involvement of FACT in cancer came from work by Xiang and colleagues, where 
they monitored the expression of SSRP1 using northern blot and in situ hybridization in 
rat fetal kidney, adult kidney, and renal cell carcinoma induced by Fe-nitrilotriacetate. 
Northern blot analysis showed that SSRP1 was expressed in rat fetal kidney and renal cell 
carcinoma but not in the adult kidney. Further investigations using in situ hybridization 
led to the discovery that SSRP1 localizes in epithelial cells of fetal kidney, and neoplastic 
cells of renal cell carcinoma but not in cells of normal adult kidney, suggesting that SSRP1 
might have a role to play in kidney development and carcinogenesis (Xiang et al., 1996). 
Subsequent work by Hudson and colleagues, using protein microarrays and 
autoantibodies from cancer patients, also identified SSRP1 as one of the proteins that is 
aberrantly expressed in ovarian cancer (Hudson et al., 2007). In addition, analyses of 
publicly available mRNA expression datasets showed that the expression of FACT is 
strongly associated with embryonic development, stem cells and differentiation, and 
oncogenes activity in mammals. Also, when C2C12 myoblasts were induced to 
differentiate into myotubes, the levels of FACT subunits were reduced, suggesting that 
the expression of FACT may be necessary to keep cells in an undifferentiated state (Garcia 
et al., 2011). Also, Koman and colleagues in their work with MMTV-neu transgenic mice, a 
model for breast cancer development discovered that SSRP1 was highly induced (Koman 
et al., 2012). FACT has been shown to drive metastasis in breast and lung cancer (Garcia 
et al., 2013). A recent report by Ding and colleagues implicated SSRP1 as a driver of 
metastasis in patients with hepatocellular carcinoma (HCC) (Ding et al., 2016). Ding and 
colleagues analyzed publicly available RNA expression data from patients with HCC and 
showed that levels of SSRP1 were increased. SSRP1 protein levels were also high in most 
HCC cell lines. In the bid to find out whether the high SSRP1 expression influence certain 
clinicopathologic factors in HCC patients, Ding and colleagues demonstrated that high 
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SSRP1 correlated with faster carcinoma enlarging and spreading. In addition, HCC patients 
with very high SSRP1 in their tumors have a shorter overall survival. In order to gain more 
insight into the role of FACT in HCC, levels of SSRP1 were manipulated in HCC cell lines. 
The knockdown of SSRP1 in HCC cells led to a significant increase in cell apoptosis. FACT 
therefore has become a therapeutic target to a class of anticancer drugs called curaxins 




Role of FACT in gene expression 
2.1 Introduction 
A number of evidence supports FACTs role in regulating RNA transcription. As 
noted earlier, the human FACT was initially identified and purified using biochemical 
methods as an activity that stimulates transcription elongation over a chromatinized 
template in vitro (Orphanides et al., 1998). Crosslinking followed by ChIP-qPCR of FACT on 
active Pol II genes demonstrates that FACT occupies transcribed regions of specific genes 
(Mason and Struhl, 2003). yFACT is involved in the disassembly of histone H2A/H2B from 
the PHO5 promoter to activate transcription, implicating FACT in transcription initiation 
(Ransom et al., 2009). 
Conditional inactivation of Spt16 in yeast results in decreased binding of members 
of the pre-initiation complex, TBP and TFIIB at normal promoters (Mason and Struhl, 
2003). On the other hand, the mutations in Spt16 results in transcription from cryptic 
promoters within the coding regions of some genes. This suggests that FACT plays a role 
in preventing inappropriate transcription initiations from promoter-like regions in cells 
(Kaplan et al., 2003; Mason and Struhl, 2003). Relatively little is known about 
contributions of FACT to gene regulation in higher eukaryotes and, beyond evidence that 
FACT depletion leads to changes in expression of only a few genes in human cell line (Li et 
al., 2007), there is little information about the effects of FACT on gene expression 
genome-wide. Results of microarray analyses suggest that FACT depletion leads to either 
up- or down-regulation of only ~1.3% of the 8308 genes tested in human cells.  
In this chapter, I begin to explore roles of FACT in global gene regulation in 
Metazoa, using Drosophila S2 cells as a model system. In initial experiments, I use 
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Chromatin immunoprecipitation to determine whether FACT is enriched at transcribed 
regions of the genome. In addition, I use RNA-seq to explore and define the consequences 
of SSRP1 and Spt16 depletion on transcript accumulation, genome-wide. 
2.2 Materials and Methods 
2.2.1 Cell culture 
Drosophila S2 cells (GIBCO) were conditioned and maintained in Schneider’s 
medium (GIBCO, # 21720) supplemented with 10% heat-inactivated fetal bovine serum 
(PAA, #A15-701) at 25°C prior to treatment with the dsRNA. All tissue culture 
manipulations were carried out in the tissue culture hood 
2.2.2 Making double stranded RNA 
2.2.2.1 Design of double stranded RNA 
Double-stranded RNA (dsRNA) for RNAi was generated essentially as described 
(Blanchette et al., 2009); (Blanchette et al., 2005; Clemens et al., 2000). Briefly, the 
double stranded RNA (dsRNA) was generated from a PCR template carrying a T7 RNA 
polymerase promoter sequence (5'-TAATACGACTCACTATAGG-3') on each end. The 
primers for making the template begin with the T7 RNA polymerase promoter sequence 
5'-TAATACGACTCACTATAGG-3' followed by a gene specific sequence of approximately 20-
30 bp (see next section OR Table 1). For optimally effective knockdown, the dsRNA should 
be at least 400 bp long. In order to reduce the occurrence of false positive phenotypes, 
two non-overlapping dsRNA targeting the gene of interest were used for most RNAi 
experiments. As a negative control, dsRNA targeting eGFP (enhanced green fluorescent 
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protein) was generated. eGFP was used as control since it has either no sequence 
homology to the fly genome. 
Table 2-1 Primer list for making T7 template 












2.2.2.2 T7-DNA template amplification 
PCR reactions were carried out using 1X Amplitaq buffer (source, cat #), 200 µM 
each dNTP, 0.75 µM each of the forward and reverse primers, 250 ng cDNA and 25 units 
of Amplitaq (Roche Applied Science, 11435094001) in a total volume of 500 µl. The PCR 
mixtures were aliquoted into eight 0.25ml PCR tubes and amplified using an Eppendorf 
thermocycler. The following conditions were used for PCR amplification: initial 
denaturation at 94°C for3 min, followed by 35 cycles of 94°C for 30s, 55°C for 30s and 




Following PCR amplification, the eight reactions were pooled, and the amplicons 
were purified using the QiaQuick PCR purification kit (Qiagen #28104). Amplicons were 
eluted from the column into 50 µl of TE (10 mM Tris HCl pH 7.5, 1 mM EDTA). DNA 
concentration of the final products were measured using a NanoDrop2000c 
Spectrophotometer, and the quality of the amplicons assessed by electrophoresis on a 2% 
agarose gel in 0.5 X TBE. 
2.2.2.3 DsRNA synthesis 
250 µl transcription reactions were assembled at room temperature and 
contained 1X of 5X HY buffer (1M HEPES-KOH pH 7.5, 100mM MgCl2, 200mM DTT, 10mM 
Spermidine-HCl and 0.5mg/ml RNAse/DNase free BSA in water), 5mM each of ATP, CTP, 
GTP, and UTP, 200 U of RNasin, 2.5 U Pyrophosphatase, 5µg of the template DNA and 150 
Units T7 RNA polymerase (Invitrogen #18033-019) in a reaction. Reaction mixtures were 
incubated overnight at 37°C. The template DNA was removed by incubating with 5 U of 
DNAse RQ1 (Promega #M6101) at 37°C for 30 minutes. The newly synthesized RNA was 
purified using the QIAGEN RNAeasy midi kit (Qiagen #75144) and eluted in 500 µl of 
water. The RNA concentration was measured using the NanoDrop2000c 
Spectrophotometer and adjusted to 1 mg/ml, 10 mM Tris pH 7.5, and 100 mM NaCl. To 
anneal RNAs, samples were heated for 5 min at 95⁰C in a heat block in a dry bath 
incubator. The heat block was removed from the incubator and allowed to cool for 1 hour 
on the benchtop at room temperature. The newly made dsRNA was run on a 2% agarose 
gel to check the quality. 
23 
 
2.2.3 DsRNA-mediated knockdown of FACT 
To deplete FACT subunits, dsRNA-mediated knockdowns were performed in 
Drosophila embryonic S2 cells using either one of the two non-overlapping double 
stranded RNAs targeting either SSRP1 or Spt16. Double stranded eGFP was used as a non-
targeting control to rule out off-target effects. All experiments were performed in 
duplicate. For each replica, about 2×106 cells were seeded in each well of a 6-well dish (35 
mm) and incubated at 25°C for 30 min to allow cells to attach to the bottom of the plate. 
Cells were then treated by adding 10 µg dsRNA to each well and incubated for 48 hours at 
25 degrees Celsius. A second dose of 10 µg dsRNA/well was added and the cells harvested 
after 48 hours to study the loss of function phenotypes. Cells were washed twice using 1 
ml 1X PBS by centrifugation at 1500 x g for 5min at 4°C and resuspended in 500 µL 1X PBS. 
A western blot was performed using 10% of the cells to check the knockdown specificity 
and efficiency. A knockdown of at least 80% was considered acceptable for the 
downstream experiments. 
2.2.4 Custom made SSRP1 and Spt16 antibodies 
2.2.4.1 Cloning of full length SSRP1 and Spt16/dre4 constructs 
Anti-SSRP1 and anti-Spt16/dre4 polyclonal antibodies were generated by 
independently injecting rabbits (YenZym Antibodies, LLC) with full length SSRP1 and 
Spt16/dre4 recombinant proteins bearing an N –terminal Pseudomonas endotoxin. 
Antibody against SSRP1 and Spt16/dre4 were then affinity purified from sera using CNBr 
column previously coupled with his-tag purified SSRP1 and Spt16/dre4. Full length SSRP1 
and Spt16/dre4 were cloned into Gateway pDONR™221 vectors yielding entry clones of 
SSRP1 and Spt16/dre4. Briefly, attB-modified custom primers were used to generate attB-
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PCR products of SSRP1 and Spt16/dre4 using the Drosophila cDNA as template. To clone 
attB-PCR products into the pDONR221 donor vector, 50 fmol of attB-SSRP1 PCR product 
and 50 fmol of attB-Spt16/dre4 were independently mixed with 150 ng pDONR™221 
plasmid vector in 1 X TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0), and 2 µl BP Clonase™ in 
a 10 µl reaction and incubated at 25 °C for 1 h. To stop the reaction, 2 μg Proteinase K 
solution were added to the BP reaction and incubated at 37°C for 10 min. Competent E. 
coli cells were then transformed using 2 µl of the cloned products and selected for 
Kanamycin resistance. M13 primers and customized sequencing primers were used to 
screen for positive clones. Next, positive clones of pDONR221-SSRP1 and pDONR221-
Spt16/dre4 entry clones were each sub-cloned into Gateway destination vectors pVCH6 
(Vector has N-terminal Pseudomonas endotoxin and C-terminal 6X His tag) and PET42 
(Vector has C-terminal 6X His and V5 epitope) by performing the LR recombination 
reaction. Again, competent E. coli cells were transformed using 2 µl of the cloned 
products and selected for ampicillin resistance. M13 primers and customized sequencing 




Table 2-2 Primers for cloning FACT into Gateway vectors 
Primer name 5’ - 3’ sequence 
attB2-SSRP1.rev GGG GAC CAC TTT GTA CAA GAA AGC TGG GTA ATC ACT GGC CTC ATC TTC 
attB1-SSRP1.fwd GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT AAT GAC AGA CTC TCT GGA G 
attB2-Dre4.rev GGG GAC CAC TTT GTA CAA GAA AGC TGG GTA ATG TCG CGA CTT CTT CGA 
attB1-Dre4.fwd GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT AAT GTC GAG CTT TGT GCT G 
SqP SSRP1_seqR_06 CTG CTC GGT CAT CTT TAG GC 
SqP SSRP1_seqR_05 AGA TGG TCT TCG ACT CCT TG 
SqP SSRP1_seqR_04 GTC TTG CCG TGC AGC TGG AA 
SqP SSRP1_seqR_03 GAT AAA GTT ACC GGG TCC GG 
SqP SSRP1_seqR_02 CTT GCC CAT GTT GCT GAC AT 
SqP SSRP1_seqR_01 TCT TTC TTC TCG GAC TTC TT 
SqP SSRP1_seqF_3 GAG CTG AAG GAC AAG TCC AA 
SqP SSRP1_seqF_2 GCT CAA GAA CGG AAC TGT TC 
SqP SSRP1_seqF_1 ATG AGC AAG GCC TCG GTC ATC TCG 
SqP D221-Dre4.rev_05 TTG CAG GGC TTT GAT GAG CT 
SqP D221-Dre4.rev_04 CGT AGA CGT CGC ACA GCT TT 
SqP D221-Dre4.rev_03 AGC TCC TTG ACT TCC GGC TC 
SqP D221-Dre4.rev_02 GAA ATG CAG AAG AAT GAT CA 
SqP D221-Dre4.rev_01 TCC AGC CGC CTT GTT CAA AG 
SqP D221-Dre4.fwd_05 TGG CTC TGA TGA GGA ATC TG 
SqP D221-Dre4.fwd_04 AGA CTG CCT TCA AGA GCT TC 
SqP D221-Dre4.fwd_03 GCC ACA ATG GGT CGC AAC GA 
SqP D221-Dre4.fwd_02 GGG CAT CTC GAA TCT GAC CA 
SqP D221-Dre4.fwd_01 ACA ACA TAC GCA AGG CAT CG 
  
2.2.4.2 Expression of FACT constructs in Bacteria 
Positive clones of pDONR™221-SSRP1 and pDONR™221-Spt16/dre4 were sub 
cloned into pET-DEST42 and pVCH6 gateway destination vectors. BL21 (DE3) Rosetta 
pLysS (Novagen) were independently transformed with pET-DEST42-Spt16/dre4, pET-
DEST42-SSRP1, pVCH6-SSRP1, and pVCH6-Sp16/dre4 plasmids, plated on LB plates, and 
incubated overnight at 37 °C. A colony from each plate was picked and used to inoculate 
150 ml of 1 X LB supplemented with 34 µg/ml chloramphenicol and 50 µg/ml ampicillin, 
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and incubated at 37˚C overnight on a shaker. For each construct, Six 1 L 1X LB 
supplemented with 34 µg/ml chloramphenicol and 50 µg/ml ampicillin were inoculated 
with 25 ml of the overnight culture and incubated at 37°C on the shaker until culture 
reached O.D.600 = 0.7 AU. Prior to induction, 1 ml of the culture were taken, spun down, 
and resuspended in 140 µl 1X sample buffer in 0.1 M DTT for western blot analyses. The 
recombinant protein expression were then induced by adding 1 ml of 1 M IPTG to the 
culture at O.D.600 0.7 AU and incubated for 3 hours with agitation at 37˚C. Another 1 ml 
aliquots were taken for western blot analyses. The remaining bacteria cultures were 
harvested in 1 L bottles by centrifuging at 6,000 x g for 15 min at 4˚C. Cell pellets were 
washed once using 50 ml 1X PBS, centrifuged at 6,000 x g for 15 min at 4˚C, and stored at 
-80°C 
2.2.4.3 Cell lysis and fractionation of pVCH6-SSRP1 and pVCH6-Spt16/dre4 antigens 
under denaturing conditions 
PVCH6-SSRP1 and pVCH6-Spt16/dre4 recombinant proteins were purified under 
denaturing conditions. Prior to purification, bacteria pellets harvested from 2 L cultures 
were each resuspended in ~ 150 ml of lysis buffer (50 mM Tris-Cl pH 7.5, 1 M NaCl, 20 
mM Imidazole pH 7.5, 6 M Urea, 0.1 % Triton X-100, 1x EDTA free Protease Inhibitor, 
Roche), and sonicated using the Branson digital sonifier micro tip at 50 % amplitude for 5 
cycles, where each cycle is 1 min burst of sonication followed by 60 s pause on ice. 
Soluble proteins were then recovered from the supernatant following centrifugation at 
45,000 RPM for 45 min at 4˚C. The supernatant were filtered once in a 0.45 µm CN filter 
followed by a 0.20 µm CN filter.  
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2.2.4.4 Nickel affinity purification of pVCH6 antigens under denaturing conditions 
Purification of pVCH6 proteins were performed under denaturing conditions on 
the FPLC system using a Ni2+-charged 1 ml HiTrap Chelating HP column. Using a syringe, 
the 1 ml HiTrap Chelating HP column was washed with 5 column volumes of water, 
loaded with 2 ml 0.5 M NiSO4, and washed twice with 5 column volumes of water (1 
drop/s). Buffer A (50 mM Tris-Cl pH 7.5, 1M NaCl, 6M Urea, 0.1% Triton X-100) and buffer 
B (50 mM Tris-Cl pH 7.5, 1M NaCl, 500 mM Imidazole, 6M Urea, 0.1% Triton X-100) were 
installed and a “pump wash” was run at 4°C on the AKTA purifier 10 (GE Healthcare). 
Next, the Ni2+-charged 1 ml HiTrap Chelating HP column was installed, the samples were 
loaded on to the injection inlet, and a 20 column volume gradient from 4 % to 100 % 
buffer B was run. The flow through were recovered into 50 ml conical tubes from valve 3 
outlet, and 500 µl eluate fraction were collected during the gradient phase into capless 
tubes using the fraction collector. Protein gels of the un-induced culture, induced culture, 
purification flow through, and the eluate fractions were run and stained using Coomasie 
blue. The peak fractions were collected and pooled together 
2.2.4.5 Cell lysis and fractionation of pET-DEST42 recombinant proteins under native 
conditions 
Prior to purification of pET-DEST42 recombinant proteins, pellets were 
resuspended in 50 ml lysis buffer (50 mM Tris-Cl pH 7.5, 1 M NaCl, 20 mM, 2mM 
MgCl2Imidazole pH 7.5, 0.1% Triton X-100, 1 x Protease Inhibitor Roche EDTA free), and 
finally treated with 1250 U Benzonase I. DNA was sheared again by sonicating lysates on 
ice using the Branson digital sonifier micro tip at 50 % amplitude for 5 cycles (where each 
cycle is 1 min burst of sonication followed by 60 s pause). Soluble proteins were 
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recovered in the supernatant following centrifugation at 45,000 RPM for 45 min at 4°C. 
The supernatant were filtered once in a 0.45 µm CN filter followed by a 0.20 µm CN filter. 
2.2.4.6 Nickel affinity purification of pET-DEST42 recombinant proteins under native 
conditions 
Purifications of pET-DEST recombinant proteins were performed under native 
conditions on FPLC System using a Ni2+-charged 1 ml HiTrap Chelating HP column. Using a 
syringe, the 1ml HiTrap Chelating HP column was washed with 5 column volumes of 
water, loaded with 2 ml 0.5 M NiSO4, and washed twice with 5 column volumes of water 
(1 drop/s). Buffer A (50 mM Tris-Cl pH 7.5, 1M NaCl) and buffer B (50 mM Tris-Cl pH 7.5, 
1M NaCl, 500 mM Imidazole) were installed, and a “pump wash” was run at 4°C on the 
AKTA purifier 10 (GE Healthcare). Next, the Ni2+-charged 1 ml HiTrap Chelating HP 
column was installed, the samples were loaded on to the injection inlet, and a 20 column 
volume gradient from 4 % to 100 % buffer B was run. The flow through were recovered 
into 50 ml conical tubes from valve 3 outlet, and 500 µl eluate fraction were collected 
during the gradient phase into capless tubes using the fraction collector. Protein gels of 
the uninduced culture, induced culture, purification flow through, and the eluate 
fractions were run and stained using Coomasie blue. The peak fractions were collected 
and pooled together. 
2.2.4.7 Antigen coupling to Cyanogen bromide-activated-Sepharose 4B CNBr-Sepharose 
beads 
Purified recombinant proteins from the Ni-column were dialyzed in 500 ml 
coupling buffer (50 mM Na-Borate, pH 8.5, 500 mM NaCl, and 2 M urea) for 3 hours 
(buffer was replaced every hour with fresh buffer). 50 µl of the dialyzed input proteins 
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were saved to be used to evaluate the coupling efficiency. 0.5 g CNBr-Sepharose 4B (GE 
Healthcare 17-0430-1) were swelled in 50 ml of cold 100 mM HCl and incubated on the 
rocker for 30 min at 4 ˚C. The swollen CNBr-Sepharose beads were washed on a fritted 
funnel using 200 ml of cold 100 mM HCl under very light vacuum. The washed beads were 
transferred into a 15 ml conical tube, and supernatant discarded after centrifugation at 
750 x g for 30 s. Next, beads were equilibrated in 10 ml of cold coupling buffer and the 
supernatant discarded after centrifugation at 750 x g for 30 s. 2 ml 50% equilibrated 
CNBr-bead slurry were mixed with 2.5-8 mg of the dialyzed recombinant protein and 
incubated on the rocker at room temperature for 2-4 h. the ligand-bound CNBr-beads 
were then spun at 750 x g for 30 s and 100 µl of the supernatant were saved for 
evaluating the coupling efficiency. The remaining CNBr-Sepharose reactive groups were 
blocked by adding 1 ml of 1M Ethanolamine pH 8.0 and incubated at room temperature 
for 1 h on the rocker. Next, ligand-bound beads were spun for 2 min at 750 x g, and the 
supernatant removed. At this stage, the beads were transferred to columns and washed 
thrice using 5 ml buffer A (50 mM Na-Acetate pH 4.0, 500 mM NaCl), thrice using 5 ml 
buffer B (50 mM Na-Borate pH 8.0, 500 mM NaCl), and twice using 5 ml 1 X PBS. 60 µl of 
2% sodium azide were added to columns prior to storage at 4 ˚C.  
2.2.4.8 Affinity purification of SSRP1 and Spt16 antibodies from Serum 
1 ml antigen-bound beads (1ml) were mixed with serum in a 50 ml falcon tube and 
incubated at 4˚C overnight on a rotator. Sera/beads mixture were loaded onto a 10 ml 
BioRad econo-column fitted with a 16G1 needle connected to 20-30 cm of 0.062”/0.082” 
I.D./O.D. polyethylene. The columns were then rinsed five times using 10 ml 1 X PBS. 
Columns were washed again sequentially using, 10 ml of Wash A (50 mM Tris pH 8.0, 120 
mM NaCl, 0.5 % NP-40), 10 ml of Wash B (50 mM Tris pH 8.0, 1 M LiCl, 0.5 % NP-40), 10 
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ml of Wash A and 10 ml of 1 X PBS. After the washes were completed, the column was 
connected to a fraction collector to collect 400-500 µl eluate into capless Eppendorf 
containing 7.5 µl of 2 M Tris-base. Antibodies were eluted by adding 5 ml of elution buffer 
(150 mM NaCl, 50 mM Glycine-Cl pH 2.5) to column. Bradford assay were performed by 
mixing 5 µl of each fraction to 100 µl of Bradford reagent, Coomassie Plus (Thermo 
SCIENTIFIC, 23238). Fractions with high concentration of antibody (measured using 
Bradford assay) were pooled together. For storage, 2% Sodium azide was added to each 
pooled fraction to 0.02 % final concentration 
2.2.5 Western blotting 
Saved aliquots of cell suspension were resuspended in NuPAGE LDS sample buffer 
(Invitrogen, NP0007) containing 0.1 M DTT, sonicated using a BRANSON digital sonifier at 
4°C using 100 % amplitude for 3 cycles (where each cycle is a 60 s burst of sonication, 
followed by a 60 s pause), and heated at 70 °C for 10 min. 10 µl aliquots of reduced 
samples were loaded into wells of a NuPAGE Novex 4-12 % bis-tris SDS-PAGE gradient gel 
(Life tech, NP0322BOX) and run using 1 X MES (50 mM MES, 50 mM Tris Base, 0.1 % SDS, 
1 mM EDTA, pH 7.3) buffer and 500 µl NuPAGE antioxidant (Invitrogen, NP0005) at 120 v 
for ~2 h. The resolved proteins were then transferred onto a pre-activated Immobilon-FL 
PVDF transfer membrane (EMD Millipore, IPFL00010) using a Genie electrophoretic 
transfer system (Idea Scientific Co.). The transfer was carried out using 1 X transfer buffer 
(25 mM Tris base, 188 mM Glycine, 10 % Methanol) at 24 v for 1h 15 min. After transfer, 
membranes were washed once with 1X PBS and blocked for an hour using Odyssey 
blocking buffer (LI-COR, 927-40000). To probe, the membranes were incubated in 1:5000 
primary antibodies in Odyssey blocking buffer at room temperature for at least an hour. 
Unbound primary antibodies were washed 3 x 5 min, by incubating membrane in buffer 
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containing PBST (1 X PBS + 0.1 % Tween-20) at room temperature with gentle shaking. In 
order to visualize, blots were incubated the blot in a 1:10000 fluorescently-labeled 
secondary antibody in Odyssey blocking buffer for 45 min, washed, and scanned using the 
Odyssey fluorescence imaging system (LI-COR Biosciences). 
2.2.6 Chromatin Immunoprecipitation of FACT subunits 
2.2.6.1 Formaldehyde crosslinking, sonication and immunoprecipitation 
Chromatin immunoprecipitation was performed as described (Lee et al., 2006). 
Briefly, Formaldehyde crosslinking was performed by adding an equal volume of 2% 
formaldehyde solution (900 µL 16% formaldehyde in 7.3 ml 1 X PBS) to the resuspended 
cells and incubated at room temperature for 20 min. The formaldehyde crosslinking was 
quenched by adding 1/20 volume of 2.5 M glycine to the cells in suspension. The cells 
were then washed twice using ice-cold 0.125 M glycine in 1 X PBS. Next, the cell pellet 
was resuspended in 500 µL buffer A2 (15mM HEPES pH 7.5, 140 mM NaCl, 1mM EDTA, 
0.5 mM EGTA, 1 % Triton-X 100, 0.1% Sodium deoxycholate, 1 % SDS, 0.5 % N-
lauroylsarcosine, protease inhibitor Cocktail-Sigma P8849). The nuclei were pelleted by 
spinning at 3500 x g for 5min at 4 °C. The supernatant was carefully discarded and nuclei 
resuspended in 800 µl Buffer A2. The extracted nuclei were sonicated using the Misonix 
3000 sonicator at 4°C using output power 3 (9 w power) for 10 cycles (where each cycle is 
a 10 s burst of sonication, followed by a 60 s pause) and spun at 14000 rpm at 4°C for 10 
min. A 30 µL aliquot of the sheared chromatin (supernatant) was saved as input sample to 
normalize the eluate signals and to check the sonication efficiency. Prior to the 
immunoprecipitation, 25 µl Pierce Protein A/G Magnetic Beads (Invitrogen, 88803) were 
washed twice using BSA solution (0.5% BSA in 1X PBS). Next, 10 µg of anti-SSRP1 (T. 
Tettey and M. Blanchette), 10 µg of anti-Spt16 (T. Tettey and M. Blanchette) and 10 µg 
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Normal Rabbit IgG (Santa Cruz, sc-2027) in BSA solution were coupled to the washed 
Protein A/G beads for 4 hours at 4°C. The antibody-conjugated Dynabeads were then 
washed twice using 0.5% BSA in 1X PBS. The sheared chromatin was then added to the 
antibody-conjugated Protein A/G beads and incubated overnight at 4°C. The Protein A/G 
beads-antibody-protein complex were washed twice using a low salt buffer (20mM Tris-
HCl, 150mM NaCl, 2mM EDTA, 1% Triton X-100), once with a high-salt buffer (20mM Tris-
HCl, 500 mM NaCl, 2mM EDTA, 1% Triton X-100) and once with a LiCl buffer (20 mM Tris-
HCl, 250 mM LiCl, 1 mM, 1% Triton X-100, 0.1% NP-40, 0.5% sodium deoxycholate) at 4°C. 
Washed Protein A/G-antibody-protein complexes were resuspended in 150 µl elution 
buffer (50mM Tris pH 8.0, 10mM EDTA, 1% SDS), 150 μl TE (10 mM Tris, 1mM EDTA), and 
4 μl of 10 μg/μl RNaseA (Sigma; Cat. no. R6513). In parallel, 120 μl elution buffer, 150 μl 
TE, and 4 μl of 10 μg/μl RNaseA was added to 30 µl of each input sample. Input samples 
and Protein A/G-antibody-protein complexes were then incubated at 37°C while shaking 
on the Thermomixer for 30 min. In order to digest the proteins and reverse the 
crosslinking, 2 μl of Proteinase K solution (Invitrogen; Cat. no. 25530-049) was added to 
the eluate and incubated overnight at 65°C while shaking on the thermomixer. 
2.2.6.2 DNA purification 
DNA was extracted from the reverse crossed-linked samples using 
Phenol:Chloroform:Isoamyl Alcohol. Briefly, an equal volume of 
Phenol:Chloroform:Isoamyl Alcohol 25:24:1 (Sigma; Cat no. P3803) was added to the 
samples, vortexed and centrifuged at 15000 x g. The supernatant was carefully collected 
into fresh tubes containing 12 μl of 5M NaCl (final 200 mM) and 30 μg glycogen (Roche; 
Cat no. 901 393). DNA was precipitated by mixing the supernatant with 750 µl iced cold 
100% ethanol, incubated at -80 °C for 1 h, and spun at 20000 x g for 30min at 4°C. DNA 
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pellets were washed once using 1ml 70% ethanol, air-dried for 30min and resuspended in 
nuclease free water. 
2.2.6.3 Library preparation 
The Molecular Biology Core of the Stowers Institute prepared libraries from the 
ChIPed DNA using the KAPA HTP kit (Kapa Biosystems), sized selected using the SPRIselect 
double side size selection kit (Beckman Coulter) and sequenced on the Illumina HiSeq 
platform. 
2.2.6.4 ChIP-seq analysis 
This and all bioinformatic analyses described in this thesis were performed with 
Xin Gao, Alex Chitsazan, Benjamin Story, and Marco Blanchette. The ~30 million reads 
from each experiment were aligned using bowtie 2 to the Drosophila dm6 genome. The 
two independent biological replicates (NS1 and NS2) of the eGFP dsRNA treated cells had 
very good correlation (r = 0.98) and so data generated were averaged. ChIP-seq data 
generated from the four independent biological replicates of SSRP1 knockdown (derived 
from biological duplicates of the two unique SSRP1-dsRNA) were averaged since they had 
very good correlation (r=0.9). Therefore, all the heatmaps and metagene analyses 
represent averaged values. 
2.2.7 RNA-seq 
2.2.7.1 FACT knockdown, RNA purification and library preparation 
Two non-overlapping, ~ 400 base, dsRNAs were designed to target Spt16 and 
SSRP1. In addition, dsRNA of eGFP was used as a non-targeting control. All the double 
stranded RNA mediated knockdown experiments were performed in duplicate.  
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For each knockdown experiment 2×106 cells were seeded per well of a six-well 
plate and incubated at 25°C for 30 min to allow cells to attach to the bottom of the plate. 
Cells were treated with 10 µg dsRNA and incubated for 48 hours. The cells were again 
treated with 10 µg dsRNA and harvested after 48 hours to study the loss of function 
phenotypes. After 48 hours, cells were transferred into 2ml tubes, washed once with 1ml 
PBS, and resuspended in 100 µl 1X PBS. About 10% of the cell suspension of each sample 
was used in a western blot to determine the extent of knockdown. From the remainder of 
each sample, total RNA was prepared using the QIAGEN RNeasy mini kit (Qiagen, cat# 
74106) following the manufacturer’s protocol. The purified RNA was eluted in 80 µl of 
water. The quantity and integrity of the isolated RNA were assessed using the Agilent 
Bioanalyzer. 
The Molecular Biology Core of the Stowers Institute for Medical Research 
prepared the mRNA libraries following the Illumina TruSeq Stranded mRNA sample 
preparation protocol (Illumina, 15031047) using the TruSeq Standard mRNA LT Sample 
Prep Kit, 48; Set A (Illumina, RS-122-2101). Briefly, the polyA+ RNA was purified using 
oligo dT magnetic beads. The purified mRNAs were fragmented, randomly primed and 
reverse transcribed to generate first and second strand cDNAs. The 3’-ends of the cDNAs 
were adenylated, adaptors ligated to the ends and the final cDNA enriched through PCR. 
The libraries were then sized selected using the Pippen (Sage Science) and validated using 
Agilent 2100 Bioanalyzer. The barcoded libraries were pooled together and loaded onto a 
flow-cell for sequencing to generate 50 bp single reads. 
2.2.7.2 RNA seq analysis 
Reads from two biological replicates for each sample were aligned to the fly 
genome dm6 using the default parameters of the STAR aligner. Cuffdiff v1.3.0 was used to 
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quantify RPKM values, to perform differential expression analysis at FDR < 0.05, and to 
assess statistically sufficient read coverage for each gene.  
2.3 Results 
2.3.1 DsRNA mediated knockdown of SSRP1 or Spt16 in S2 cells were successful 
In order to determine how FACT regulates gene expression globally in higher 
eukaryotes, levels of FACT subunits were depleted in an RNAi experiment in Drosophila 
embryonic cell line S2 followed by sequencing of messenger RNA. For every target 
protein, two non-overlapping, ~ 400 base dsRNAs were designed. In addition, double 
stranded eGFP RNA was used as a non-targeting control. DsRNA mediated knockdown of 
SSRP1 or Spt16 led to a significant reduction of the protein level of both FACT subunits as 
shown in the western blot (Figure 1A). The two unique non-overlapping dsRNA targeting 
each FACT subunit yielded very similar results, indicating that the observed were not 
because of “off-target “effect of the dsRNAs. The observation that knocking down either 
SSRP1 or Spt16 reduced expression of both proteins, is consistent with prior results 
indicating that depletion of one FACT subunit leads to reduced stability of the other in 









Figure 1. DsRNA mediated knockdown of FACT, and ChIP of FACT were successful.  
(A) Western blot of Spt16 and SSRP1 in Drosophila S2 cells previously treated with eGFP, 
SSRP1, or Spt16 double stranded RNAs. Tubulin was used as a loading control. (B) IGV 
browser snapshot showing Spt16 (colored green) and SSRP1 (colored blue) localization in 
relation to RNA Pol II (Rpb3 subunit) within the Hsp22, Droj2, and Inos loci. Levels of 
Spt16 and SSRP1 were reduced in the Spt16 and SSRP1 deficient cells respectively 
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2.3.2 FACT binds along transcribed regions with bias towards 5’ ends 
To begin to characterize functions of FACT in higher eukaryotes genome-wide, I 
generated antibodies against Drosophila FACT subunits SSRP1 and Spt16 and used them 
to perform chromatin immunoprecipitation followed by high-throughput sequencing 
(ChIP-seq) experiments in Drosophila S2 cells.  To control for specificity of the SSRP1 and 
Spt16 antibodies, SSRP1 or Spt16 were each depleted using two unique double stranded 
RNAs (dsRNA). EGFP double stranded RNA was used as a non-targeting control.  
The peak finding algorithm, MACS2 (Model-based Analysis of ChIP-seq), was used 
to identify peaks (MACS 2 q ≤ 1 x 10-4) that occur in all replicate samples. Comparison of 
peaks identified by ChIP of SSRP1 and Spt16 revealed that the localization of the two 
proteins was highly correlated, as expected since they function as subunits of the same 
complex (Figures 1B, and 2B).  
At genes showing the greatest enrichment for FACT subunits, exemplified in Figure 
1B by Hsp22, SSRP1 and Spt16 ChIP signals were almost completely lost after knockdown 
of SSRP1 or Spt16, respectively.  At other genes, such as Droj2 or Inos, where SSRP1 and 
Spt16 were enriched to a lesser extent, the ChIP signals were reduced, most clearly near 
gene 5’ ends, but not lost (Figure 1B), perhaps because of the presence of residual SSRP1 
and Spt16.   
We then partitioned the genome into promoter and early transcribed region (200 
bp upstream to 1 kb downstream the TSS), gene body, and intergenic regions as shown in 
Figure 2A (first panel from left). We observed that more than 80% of the Spt16 peaks and 
90% of the SSRP1 peaks fell within promoters and gene bodies, with the majority of these 
falling within promoter and early transcribed regions (Figure 2A, panels 2 and 3 from left). 
This observation suggests that subunits of FACT bind along transcribed regions of genes 
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with a bias towards promoter regions (Figure 2A), consistent with earlier findings 
suggesting that yeast FACT binds to transcribed regions of specific genes. 
 
 
Figure 2. Preferential binding of FACT at promoters correlates strongly with Pol II 
binding.  
(A) Pie chart showing the distribution of FACT peaks across the Drosophila genome. Promoter, -
200 to +1000 relative to TSS; gene body, +1000 to end; upstream and downstream, intergenic 
regions. Both Spt16 and SSRP1 binds with a bias towards promoter regions. (B) Correlation plot of 
SSRP1 and Spt16 occupancy on genes with significant (q < 10-4) SSRP1 or Spt16 peaks in their 
promoters or gene bodies. (C) Boxplot showing that TSS regions showing the highest confidence 
FACT peaks also show highest Pol II occupancy. The smaller the MACS2 false discovery rate (q 
value) the more confidence there is in peak identification. We consider there to be no evidence 




2.3.3 FACT occupancy positively correlates with Rpb3 occupancy at promoters 
To assess the relationship between FACT and Pol II occupancy, we performed a 
ChIP of total Pol II using an antibody targeting the Pol II subunit Rpb3. As shown in Figure 
1B, regions of highest FACT enrichment in the 5’ ends of genes overlapped with but 
tended to be somewhat downstream of promoter-proximally paused Pol II. We then 
compared Rpb3 enrichment in the 5’-end of genes (200 bp upstream to 1 kb downstream 
of the TSS) in order to determine whether genes with high confidence FACT peaks in this 
region tend to be associated with more Pol II. As shown in Figure 2C, gene regions with 
higher confidence FACT peaks (MACS2 q<10-4) exhibited the highest Pol II occupancy, 
while regions with no evidence for FACT binding had much lower Pol II occupancy (Figure 
2C). Of note, results of MACS2 analysis suggest that FACT might be broadly distributed, as 
a large number of low confidence peaks (10-1≥q>10-4) were also identified, and these too 
showed increased Pol II occupancy relative to regions not bound by FACT. These 
observations are consistent with previous evidence that FACT is associated with 
transcriptionally active genes in yeast (Mason and Struhl, 2003), colocalizes with Pol II on 
Drosophila polytene chromosomes (Saunders et al., 2003), and is recruited via HP1c to 
actively transcribing Pol II in Drosophila (Kwon et al., 2010). 
2.3.4 RNAi mediated knockdown of SSRP1 and Spt16 in S2 cells affect RNA transcript 
abundance significantly 
The observation that the degree of FACT binding correlates with RNA polymerase 
II enrichment around promoters led us to ask whether loss of FACT affects transcriptional 
outcomes. To address that, I performed a poly-A selected RNA-seq on purified RNA from 
FACT depleted and control (eGFP dsRNA treated) Drosophila S2 cells. Using an absolute 
fold change of at least 1.5 and a false discovery rate of at most 0.05, we found that 
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expression of about 19% of the 7054 expressed genes (genes with CPM ≥ 5 in at least 2 
samples) was altered by knocking down either SSRP1 or Spt16. In addition, a good 
correlation was observed between the effect of knocking down SSRP1 and Spt16 on 
global gene expression (Figure 3A and B) as would be expected if the two subunits work 
together in a complex. Overall, we identified about 1298 and 262 genes whose 
expressions were significantly (p ≤ 0.05) affected by at least 1.5-fold following SSRP1 and 
Spt16 depletion respectively. Majority of genes were up-regulated following depletion of 
either Spt16 or SSRP1 subunit. RNAi mediated knockdown of SSRP1 led to about 68% of 
the affected genes being up-regulated and 32% downregulated. Similarly, about 87% of 
the affected genes were up-regulated while 13% down-regulated following knockdown of 
Spt16. Since FACT was discovered as a facilitator of chromatin transcription (Orphanides 
et al., 1998) it was also expected that the expression of some genes might be impaired 
following FACT loss. Our findings, however, suggest that the loss of FACT in vivo leads not 
only to downregulation of genes but also to more gene activation events, which could be 
expected if reassembly or disassembly of histones over genes is defective, leaving the 





The results from this chapter demonstrate that dsRNA-mediated knockdown of FACT 
subunits successfully depleted SSRP1 and Spt16 proteins. The loss of SSRP1 led to the 
reduction of the Spt16 subunit and vice versa. This observation suggest that the stability 
of FACT in Drosophila S2 cells depends on the presence of both SSRP1 and Spt16 proteins 
consistent with observations made by Safina and colleagues in mammalian cells (Safina et 
al., 2013). 
In addition, using ChIP followed by high-throughput sequencing, I observe that 
FACT subunits bind preferentially to promoter and early transcribed regions of genes and 
this correlates with RNA polymerase II enrichment around promoter regions. This 
 
Figure 3. Depletion of FACT subunits alters RNA transcript abundance.  
(A) Heatmap showing hierarchical clustering of 1335 genes that change by an absolute fold 
change of 1.5 (FDR < 0.05) in either SSRP1 or Spt16 knockdown compared to the non-targeting 
control. Green indicates fold decrease while red denotes fold increase in the FACT dsRNA treated 
cells compared to the eGFP dsRNA treated cells. (B) Correlation plot showing gene expression 
changes of all expressed genes following the knockdown of SSRP1 versus Spt16. Y-axis represents 
fold change after SSRP1 knockdown while X-axis represents fold change after Spt16 knockdown. 
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observation supports earlier in vitro studies suggesting that FACT regulates transcription 
initiation.  
Furthermore, depletion of FACT led to both up- and down-regulation of many 
transcripts, consistent with the model that FACT acts as both a negative and positive 
regulator of gene expression. Although there was a good correlation between the effects 
of SSRP1 and Spt16 depletion, the magnitude of gene expression changes was 
consistently greater following SSRP1 depletion.  
At the present time, we do not understand the mechanism(s) responsible for the 
apparent differences in SSRP1 and Spt16 function. As shown in Figure 1A, comparable 
reductions in SSRP1 levels were observed in cells treated with dsRNAs targeting either 
SSRP1 or Spt16.  In contrast, more Spt16 remains in cells treated with SSRP1 dsRNAs than 
Spt16 dsRNAs, raising the possibility that free Spt16 may remain after SSRP1 knockdown. 
Consistent with the possibility that unbalanced expression of Spt16 and SSRP1 could give 
rise to phenotypic changes, Spt16 was originally identified in an overexpression screen for 
genes that would suppress the phenotype of δ insertion mutations by changing 
transcription, and it was proposed that increased levels of Spt16 might alter function(s) of 
protein with which it normally interacts (Malone et al., 1991). 
The finding that SSRP1 mutation or depletion can have stronger phenotypes than 
Spt16 mutation or depletion is not unprecedented.  For example, microarray analyses in 
human cells showed that expression of a common set of about 120 genes was altered by 
siRNAs against either SSRP1 or Spt16; however, an additional 12 showed changes in 
expression only in SSRP1 knockdown cells (Li et al., 2007).  While Arabodopsis genetically 
modified to express reduced levels of SSRP1 are phenotypically generally similar to plants 
expressing reduced Spt16; however, the SSRP1 mutant has a stronger phenotype when 
combined with a TFIIS mutant (Antosz et al., 2017). In addition, in a population of plant 
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progenitor cells, heterozygous SSRP1 mutants, but not Spt16 mutants, exhibit defects in 




Roles of FACT in Histone Modification and Chromatin Architecture 
3.1 Introduction 
Nucleosomes, the basic unit of chromatin have been shown to be a major 
impediment to transcription initiation and elongation. Cells have therefore evolved a 
wide range of enzymes that slides, reorganizes, disassembles, reassembles, ejects, and 
covalently modify histones in an ATP dependent or independent manner in order for 
transcription to take place. The FACT complex is one of the highly potent histone 
chaperones that disassembles and reassembles nucleosomes in an ATP independent 
manner to stimulate transcription initiation and elongation in vitro (Belotserkovskaya et 
al., 2003). Work from a number of labs have hinted at the possible involvement of FACT in 
histone modifications and chromatin architecture organization based on studies in yeast 
on specific genes. Co-immunoprecipitation experiments performed in SETD2-depleted 
cells suggest H3K36me3 recruits the elongation factor FACT to transcribed regions 
(Carvalho et al., 2013), leading to the proposal that Set2 regulates recruitment of FACT 
through H3K36me3. In addition, Stanlie and colleagues observed that reducing levels of 
FACT leads to a reduction of H3K4me3 levels over Sµ and Sα regions, suggesting that 
FACT-dependent changes in H3K4me3 plays a role in Ig class switch recombination 
(Stanlie et al., 2010). A more recent study has demonstrated that yFACT functions to 
restrict H2A.Z to promoter locations since mislocalisation of H2A.Z into genic locations in 
FACT mutants leads to increase in cryptic transcription (Jeronimo et al., 2015).  
In this chapter, I begin to explore the roles of FACT in histone modifications and 
chromatin architecture in higher eukaryotes. My previous observations suggest that FACT 
binds preferentially to promoter regions and depletion of FACT leads to deregulation of 
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many transcription events in vivo. Based on these findings, I hypothesized that 
transcription is deregulated in FACT knockdown cells because nucleosomes that normally 
would block accessibility to promoters and transcribed regions are not properly re-
assembled in the wake of Pol II transcription. To begin addressing this hypothesis, I 
performed an MNase-seq and ChIP of H3 and in cells depleted of FACT to measure 
nucleosome positioning and occupancy respectively. In addition, I performed ChIPs of the 
transcription related histone variant H2Av and histone modifications including H3K4me3, 
H3K36me3 and H3K56 ac to assess chromatin state globally. 
3.2 Materials and Methods 
3.2.1 Micrococcal nuclease assay 
3.2.1.1 FACT knockdown, formaldehyde crosslinking and micrococcal nuclease digestion 
Prior to the MNase assay, 2 million cells were seeded per well in 6-well dishes and 
depleted of SSRP1 and Spt16 in an RNAi experiment as described (Clemens et al., 2000). 
Double stranded RNA made from eGFP (dseGFP RNA) was used as a non-targeting 
control. The extent of protein knockdown was determined through western blot. The 
mono-nucleosomal DNA was prepared essentially as described (Gilchrist et al., 2008). 
Briefly, the treated cells were harvested into 2ml tubes and pelleted at 1000 x g for 2 min. 
Cells were resuspended in 1 mL 1X PBS, pelleted by centrifugation at 1500 x g for 5min at 
4°C, and resuspended in 500 µl 1X PBS. 25 µl aliquots of each cell suspension were 
removed for western blot analysis. To perform the formaldehyde crosslinking, an equal 
volume of 2% formaldehyde in 1X PBS was added to cell suspensions and incubated for 45 
seconds at room temperature in 2 ml Eppendorf tubes in a Thermomixer with agitation at 
1400 rpm. Formaldehyde cross-linking were quenched by adding 50 µl of 2.5 M glycine 
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and incubating for 5 minutes at room temperature in a Thermomixer with agitation at 
1400 rpm. Crosslinked cells were then pelleted at 1000 x g for 2 min at 4 °C and washed 
using 1X PBS. Cells were permeabilized by resuspending in buffer A (10 mM Tris-HCl pH 8, 
10 mM KCl, 3 mM CaCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, Protease Inhibitor 
(Roche complete, EDTA free, lot#13744100), and 0.1% Triton X-100) and incubating on ice 
for 15 minutes with intermittent up and down pipetting using a P-200. Cell lysates were 
spun at 2500 x g for 2 min at 4 °C, and the pelleted nuclei were washed once with Buffer B 
(4 mM EDTA, 0.2 mM EGTA, Protease Inhibitor). Washed nuclei were then resuspended in 
300 µl cold Buffer B and incubated on ice for 15 minutes. Chromatin were isolated by 
centrifugation at 2500 x g, for 2 min at 4 °C and supernatant discarded. Next, the pelleted 
chromatin were resuspended in Digestion Buffer (15 mM Tris-Cl, pH 8, 60 mM KCl, 15 mM 
NaCl, 1 mM DTT, 0.25 M sucrose, 1 mM CaCl2). Twenty units of MNase were used to 
digest 200 μL of chromatin. A time course of micrococcal nuclease digestion (5, 10 and 15 
minutes at 25°C) were performed for each sample. Stop Solution containing 20mM Tris 
pH 7.4, 2% SDS, 25 mM EDTA were added, and samples were incubated for 90 min at 
65°C to reverse the cross-linking. To digest proteins, reverse-crosslinked samples were 
incubated with 1 µl proteinase K (Roche, 03115828001) at 37°C overnight in thermomixer 
at 1200 rpm. DNA was extracted using ethanol precipitation. The purified DNA was 
resuspended in 10 µl 1 X TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) buffer and treated with 
10 µg RNase A for 15 minutes at 37⁰C. The purified DNA were resolved on a 1.5 % agarose 
gel with 0.5 X TBE (40 mM Tris-HCl, 45 mM boric acid, 1 mM EDTA). Mono-nucleosomal 
DNA from samples digested for a time sufficient to yield ∼80 % DNA from 
mononucleosomes (∼150 bp) and ∼20% DNA from di- and trinucleosomes (∼300 and 
∼450 bp, respectively) were used for further analysis. The mono-nucleosomal DNA were 
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excised from the gel, purified using the QIAquick gel extraction kit (Qiagen, cat. no. 
28704) and resuspended in 10 µl of buffer EB. 
3.2.1.2 MNase-seq library preparation 
The Molecular Biology Core of the Stowers Institute for Medical Research 
prepared libraries from the purified DNA and performed paired end sequencing.  Libraries 
were prepared using the KAPA HTP Library Preparation Kit v3.12 for Illumina® Platforms 
(KAPA Biosystems, KK8234) on the Sciclone Robot following the manufacturer’s protocol. 
Prior to library preparation, dsDNA was quantified using the QUBIT high sensitivity assay. 
Briefly, for library preparation 10 ng of the DNA was end repaired, adenylated, indexed, 
and enriched using PCR. Libraries were then quantified using high sensitivity Qubit and 
High sensitivity Bioanalyser assays. The barcoded samples were pooled together and run 
on 4 lanes of the Illumina HiSeq using the rapid run protocol. 100 bp paired end reads of 
the samples were sequenced. 
3.2.1.3 MNase-seq analysis 
15 million reads were mapped using Bowtie 2 (parameter –no mixed, - no 
discordant) to the D. melanogaster genome dm6 Ens84. Average insert size was 
calculated using Picard CollectInsertSizeMetrics. Reads with lengths between 120 and 180 
(representing mono-nucleosomal DNA) were used for downstream analysis. Reads were 
then resized to 146 bases from the center of each read.  
3.2.2 Chromatin Immunoprecipitation of H3K4me3, H3K36me3, H2Av and H3K56ac 
3.2.2.1 Cell culture, dsRNA mediated knockdown of FACT and western blot 
Prior to Chromatin immunoprecipitation (ChIP) of histone H3, histone marks 
(H3K36me3, H3K4me3 and H3K56ac), and histone variants (H2Av), I performed an 
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independent knockdown of Spt16 and SSRP1 in Drosophila embryonic S2 cells as 
described above.  
3.2.2.2 Formaldehyde crosslinking, sonication and immunoprecipitation 
Chromatin immunoprecipitation was performed as described above using 10 µg 
anti-H3 (ab1791, Abcam), 10 µg of anti-H3K36me3 (ab9050, Abcam), 10 µg of anti-
H3K4me3 (ab8580, Abcam), 10 µL of rabbit anti-H2AvD serum (Rabbit anti-Drosophila 
H2A variant, (Leach et al., 2000)) in BSA solution coupled to the washed Dynabeads for 4 
hours at 4°C.  
3.2.2.3 DNA purification 
DNA was extracted from the reverse crossed-linked samples using 
Phenol:Chloroform:Isoamyl Alcohol resuspended in nuclease free water as described 
above. 
3.2.2.4 Library preparation 
The Molecular Biology Core of the Stowers Institute prepared libraries from the 
ChIPed DNA using the KAPA HTP kit (Kapa Biosystems), sized selected using the SPRIselect 
double side size selection kit (Beckman Coulter) and sequenced on the Illumina HiSeq 
platform. 
3.2.2.5 ChIP-seq analysis 
The ~30million reads from each experiment were aligned to the drosophila dm6 
Ens84 genome using default parameters of Bowtie 2. ChIP-seq reads were then extended 




3.3.1 Loss of FACT is associated with a subtle decrease in nucleosome occupancy and 
positioning 
Based on our results and published data, I hypothesized that “transcription is 
deregulated in FACT knockdown cells because nucleosomes that normally would block 
accessibility to promoters and transcribed regions are not properly reassembled in the 
wake of Pol II transcription”. To begin addressing this hypothesis, I mapped nucleosome 
positions using micrococcal nuclease digestion followed by sequencing (MNase-seq), and 
measured histone occupancy by performing a ChIP of histone 3 followed by high 
throughput sequencing.  
Metagene analysis of ChIP-seq of endogenous H3 across TSS and TES showed 
accumulation of H3 across the entire breath of transcribed region. I observed only 
minimal changes in H3 following the knockdown of FACT subunits compared to the eGFP 
dsRNA treated S2 cells (Figure 4A). The effects of the loss of either SSRP1 or Spt16 on H3 
levels correlate very strongly. Since the depletion of the SSRP1 subunit showed the 
biggest change in RNA transcript accumulation compared to the loss of the Spt16 subunit 
of FACT, one would have expected that SSRP1-dependent change in H3 would have been 
more pronounced. This observation was unexpected, as yeast FACT has previously been 
demonstrated to regulate histone occupancy. One possible interpretation is that other 
chaperones or chromatin modulators in S2 cells may compensate for the loss of FACT. 
To determine nucleosome positioning, I performed MNase-seq by subjecting 
cross-linked chromatin isolated from eGFP dsRNA and SSRP1 dsRNA treated S2 cells to 
micrococcal nuclease (MNase) digestion followed by paired end sequencing of the mono-
nucleosomal DNA. Micrococcal nuclease preferentially cuts the linker DNA between 
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nucleosomes leaving footprints of mainly nucleosome protected DNA (Figure 4B). An 
average gene plot of the read distribution of mono-nucleosomal DNA around the TSS and 
transcribed regions of all expressed genes showed a nucleosome depleted region around 
the TSS and well positioned +1, 2, and 3 nucleosomes within transcribed regions (Figures 
4C and 4D). Next, we observed a subtle decrease of MNase-seq signal at the +1 
nucleosome in the Spt16 (Figure 4C) and SSRP1 (Figure 4D) depleted cells compared to 
the eGFP dsRNA treated S2 cells. Overall, however, I find no major changes neither in 
nucleosome occupancy (measured by chromatin immunoprecipitation of Histone H3), nor 
in nucleosome positioning (determined by MNase-seq) in the Drosophila FACT 
knockdown compared to previous reports of defects in yeast FACT mutants. One 
explanation for this discrepancy may be that as transcription programs in Drosophila are 
more complex than those of yeast, Drosophila S2 cells may have evolved mechanisms 








3.3.2 Loss of FACT leads to reduction of promoter H2Av 
Since we observed no major change in overall nucleosome positioning and 
occupancy, we asked whether FACT-dependent changes in gene expression could be 
 
Figure 4. Loss of FACT has minimal effects on nucleosome occupancy and positioning at 
promoters and transcribed regions globally.  
(A) Metagene analysis showing H3 enrichment by ChIP-seq over transcribed regions in 
Drosophila cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA (marked in blue), Spt16 
dsRNA (marked green), aligned to the TSS and the TES. (B) 1.5% agarose gel showing a time 
course digestion of chromatin using micrococcal nuclease. Mono-nucleosomal DNA marked in 
red was excised, purified, and subjected to high-throughput sequencing. (C) Metagene analysis 
showing nucleosome positioning determined by MNase-seq in cells treated with eGFP dsRNA 
(marked red) and cells treated with Spt16 dsRNA (marked in green) over transcribed regions 
aligned to the TSS. (D) Metagene analysis showing nucleosome positioning in cells treated with 
eGFP dsRNA (marked red) and cells treated with SSRP1 dsRNA (marked in blue) over transcribed 
regions aligned to the TSS, as determined by MNase-seq. The 2023 non-overlapping genes 
included in both metagene analyses are active (have normalized promoter PRO-seq signal 
greater than 1 RPKM), longer than 0.5 kb and have no neighboring genes within 200 bp to reduce 
signals associated with nearby genes. Shaded area represents 95% confidence interval. 
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associated with changes in chromatin architecture around promoter regions or elsewhere 
in and around genes. Recent studies by Jeronimo and colleagues demonstrated that yeast 
FACT is necessary to restrict a specific variant of H2A called H2A.Z to promoter regions. 
They discovered that the loss of yeast FACT leads to an increase in H2A.Z within genic 
regions due to mislocalized SWR-C (Jeronimo et al., 2015). FACT-dependent increase in 
H2A.Z in genic locations also correlated with an increase in cryptic transcription. This 
suggests that FACT can regulate transcription outcomes by regulating positioning of 
H2A.Z. To test this possibility, I performed a ChIP of H2Av (the drosophila orthologue of 
H2A.Z) in eGFP dsRNA treated and SSRP1 or Spt16 dsRNA treated cells followed by high-
throughput sequencing. A metaplot of the distribution of H2Av reads across the 
transcription start sites and poly-adenylation sites of expressed genes (Figure 5) showed 
high accumulation of H2Av variant at about 200 bp downstream the TSS which levels off 
across transcribed regions and towards the poly-adenylation site consistent with 
published datasets (Bruce et al., 2005; Guillemette et al., 2005; Raisner et al., 2005; Zhang 
et al., 2005). The average effect of the loss of Spt16 on the position and occupancy of 
H2Av was only subtle; however, SSRP1-dependent changes in H2A.v at promoters were 
more pronounced, consistent with evidence that FACT is needed to retain H2A.v at 







3.3.3 Loss of FACT alters patterns of histone modifications associated with promoters 
of transcribing genes 
Over the years, residues on histone tails have been shown to be post-
translationally modified by specialized enzymes. These modifications have been shown to 
be associated with transcription activation, repressed chromatin states, and cell cycle 
progression. Trimethylation of H3K4 has been shown to be associated with promoters of 
active genes (Pokholok et al., 2005). H3K4me3 methyl transferase interacts with Ser5P Pol 
II CTD therefore modifies H3K4 in a transcription dependent manner. Using ChIP followed 
by qPCR, Stanlie and colleagues demonstrated that FACT can regulate H3K4me3 in Ig class 
 
Figure 5. Loss of FACT leads to minimal changes in global H2Av occupancy.  
Metagene analysis showing H2Av enrichment by ChIP-seq over transcribed regions in Drosophila 
cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA (marked in blue), Spt16 dsRNA 
(marked green), aligned to the TSS and the TES. The 2023 non-overlapping genes included in 
both metagene analyses are active (have normalized promoter PRO-seq signal greater than 1 
RPKM), longer than 0.5 kb and have no neighboring genes within 200 bp to reduce signals 
associated with nearby genes. Shaded area represents 95% confidence interval. 
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switch recombination (Stanlie et al., 2010) over Sµ and Sα gene loci. Our observation that 
loss of FACT leads to deregulation of gene expression led us to ask whether FACT 
dependent changes in RNA transcript accumulation could be explained by changes in 
modified chromatin associated with promoters and transcribed genes. To begin to test 
that, I performed a ChIP of H3K4me3 in eGFP dsRNA treated and FACT depleted cells, 
followed by high-throughput sequencing. As expected, in control cells, a strong 
enrichment of H3K4me3 at gene 5’ ends was observed in both average gene plots and at 
individual genes, exemplified in Figure 6B by Inos and 18w. Surprisingly, H3K4me3 signals 
were drastically reduced at promoters, and increased across transcribed regions in the 
FACT depleted Drosophila S2 cells. The effect of loss of FACT on H3K4me3 were evident 
on majority of transcribed genes. To rule out the possibility that the observed FACT-
dependent changes in H3K4me3 were not due to FACT-dependent changes in bulk of 
nucleosomes, we normalized the H3K4me3 reads to H3. The FACT-dependent changes in 
H3K4me3 were still evident after normalizing to H3 since the FACT-dependent changes in 
H3 was minimal. Our observations thus far demonstrate that FACT is a key regulator of 
H3K4me3 and that FACT-dependent changes in H3K4me3 is much more widespread and 
could possibly explain the changes in transcription. In addition, the 5’ -> 3’ shift in 
H3K4me3 following loss of FACT could be consistent with an increase in Pol II release into 
gene bodies. Since Set1, the H3K4me3 methyltransferase, interacts with Pol II, it is not 
inconceivable that the 5’ -> 3’ shift in H3K4me3 is due to FACT-dependent 5’ -> 3’ shift in 





3.3.4 Loss of FACT alters patterns of histone modifications associated with transcribed 
regions 
Next, we asked whether transcriptional changes in FACT knockdown cells because 
nucleosomes bearing modified histones are not properly reassembled within transcribed 
regions in the wake Pol II passage. Trimethylation of histone H3 at lysine 36 has been 
shown to be strongly associated with transcription across gene bodies (Pokholok et al., 
2005). In addition, the H3K36me3 methyltransferase, Set2, has been proposed to 
modulate the recruitment of FACT (Carvalho et al., 2013). I therefore performed a ChIP of 
H3K36me3 in eGFP dsRNA treated and FACT depleted cells, followed by high-throughput 
sequencing. Metagene analyses of the read distribution of H3K36me3 across the TSS and 
the pA show high H3K36me3 occupancy across the gene body with bias towards the 
 
Figure 6. Depletion of FACT alters global distribution of H3K4me3.  
(A) Metagene analysis showing H3K4me3 enrichment by ChIP-seq over transcribed regions in 
Drosophila cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA (marked in blue), and 
Spt16 dsRNA (marked in green), aligned to the TSS and the TES. The 2023 non-overlapping genes 
included in both metagene analyses are active (have normalized promoter PRO-seq signal greater 
than 1 RPKM), longer than 0.5 kb and have no neighboring genes within 200 bp to reduce signals 
associated with nearby genes. Shaded area represents 95% confidence interval. (B) IGV genome 
browser snapshot comparing H3K4me3 signals in cells treated with eGFP dsRNA (blue) to SSRP1 
dsRNA (brown) within Inos and 18w loci. 
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3’end (Figures 7A and 7B) consistent with published datasets (Pokholok et al., 2005). We 
observed that in the FACT knockdown S2 cells, levels of H3K36me3 were decreased across 
the gene body compared to the eGFP dsRNA treated cells. Surprisingly, levels of 
H3K36me3 occupancy were increased beyond the polyadenylation sites of genes (Figures 
7A and 7B). These results suggest that FACT is necessary for maintaining proper 
localization of H3K36me3. Although the mechanism(s) underlying these changes are not 
known, I speculate that FACT-dependent increases in H3K36me3 beyond the poly-
adenylation site could be consistent with failure of Pol II to properly terminate. 
Furthermore, since Set2 interacts with elongating Pol II, the FACT-dependent 5’ -> 3’ shift 
in H3K36me3 could be consistent with a FACT-dependent changes in Pol II distribution or 




Figure 7. Depletion of FACT alters global distribution of H3K36me3.  
Metagene analysis showing H3K36me3 enrichment by ChIP-seq over transcribed regions in 
Drosophila cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA (marked in blue), and 
Spt16 dsRNA (marked in green), aligned to the TSS and the TES. The 2023 non-overlapping genes 
included in the metagene analysis are active (have normalized promoter PRO-seq signal greater 
than 1 RPKM), longer than 0.5 kb and have no neighboring genes within 200 bp to reduce signals 
associated with nearby genes. Shaded area represents 95% confidence interval. (B) IGV genome 
browser snapshot comparing H3K36me3 signals in cells treated with eGFP dsRNA (colored red) to 





3.3.4.1 Newly incorporated histones (H3K56ac) cannot compensate for the FACT-
dependent loss of H3K4me3 and H3K36me3 
The observations described thus far indicate that FACT plays a major role in 
maintaining the integrity of modified histones around promoters and transcribed regions 
during transcription. Upon loss of FACT activity, H3K4me3 and H3K36me3 are shifted in a 
5’ ->3’ direction during transcription. We therefore hypothesized that in order to maintain 
chromatin stability in FACT knockdown cells, new histones lacking H3K4me3 and 
H3K36me3 are incorporated by a mechanism independent of FACT activity into 
nucleosomes in regions where H3K4me3- and H3K36me3-containing nucleosomes have 
been displaced.   
To test this hypothesis, I performed a ChIP of histone 3 lysine 56 acetylation (a 
mark associated with newly incorporated histones in yeast) followed by high-throughput 
sequencing in cells that had or had not been depleted of FACT. Metaplots of the read 
distribution of H3K56ac from 200 bp upstream of TSSs to 200 bp downstream of poly-
adenylation sites in both control and FACT-depleted cells showed an accumulation 
around the promoter with summit at ~200 bp downstream the TSS (Figure 8A and 8B). 
H3K56ac signals decrease gradually to background levels across the gene body to the pA 
site. We observed that in the absence of FACT, there was little or no difference in the 
amount or distribution of H3K56ac after SSRP1 depletion, and only subtle changes in 
H3K56ac after Spt16 depletion. The apparent slight increase in H3K56ac signal after Spt16 
depletion does not appear to be significant, since it is not observed consistently when we 
plot data from individual replicas of ChIPs performed with chromatin from cells treated 
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with eGFP dsRNA or the two Spt16 dsRNAs (data not shown).  If increases in H3K56 
acetylation can indeed be used as a proxy measurement for incorporation of new 
nucleosomes in Drosophila, the finding that there are at most only very modest changes 
in H3K56 acetylation makes it unlikely that that incorporation of new, unmarked histones 





In this chapter, I observed that the depletion of FACT had only minimal effects on 
histone positioning (measured by MNase-seq) and histone occupancy (measured by H3 
 
Figure 8. The depletion of FACT has no major changes in global H3K56 ac levels.  
(A) Metagene analysis showing H3K56ac enrichment by ChIP-seq over transcribed regions in 
Drosophila cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA (marked in blue), and 
Spt16 dsRNA (marked in green), aligned to the TSS and the TES. The 2023 non-overlapping genes 
included in both metagene analyses are active (have normalized promoter PRO-seq signal greater 
than 1 RPKM), longer than 0.5 kb and have no neighboring genes within 200 bp to reduce signals 
associated with nearby genes. Shaded area represents 95% confidence interval. (B) IGV genome 
browser snapshot comparing H3K56ac signals in cells treated with eGFP dsRNA (colored red) to 
SSRP1 dsRNA (colored blue) within 18w locus. 
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ChIP-seq) but alters histone marks associated with transcription. The depletion of FACT 
subunits resulted in 5’ -> 3’ shifts in H3K4me3 and H3K36me3 but no major change in 
H3K56 acetylation, which in yeast is a mark on newly incorporated histones. I can envision 
several models that could explain these findings.  First, the 5’ ->3’ shifts in H3K4me3 and 
H3K36me3 upon depletion of FACT subunits could be because FACT contributes to the 
proper localization of methyltransferases or demethylases that modify these marks. 
Alternatively, given that H3K4- and H3K36 methyltransferases interact with transcribing 
Pol II, it is not inconceivable that the 5’ ->3’ shifts in H3K4me3 and H3K36me3 could be as 
a result of changes in the distribution of Pol II across genes, perhaps due to differences in 
overall elongation rate or in the rate of escape of promoter proximally paused RNA 




Role of FACT in promoter proximal pausing  
4.1 Introduction 
The genomes of eukaryotes are highly compacted by packaging into nucleosomes 
to form chromatin. In order for transcription to take place in the cell, RNA polymerase II 
would have to gain access to promoters, initiate transcription, and elongate nascent 
transcripts within a chromatin context, where nucleosomes act as barriers limiting the 
accessibility of DNA sequences in the chromosome. Despite the tight packaging, gene 
expression is efficient because cells have evolved a collection of chromatin modifying 
enzymes, ATP dependent chromatin remodelers and histone chaperones to overcome the 
nucleosome barrier. The histone chaperone FACT is able to stimulate transcription over 
chromatinized template in vitro (Orphanides et al., 1998; Orphanides et al., 1999) by 
reorganizing nucleosomes. Furthermore, FACT works together with PTEF-b to overcome 
the basal transcription inhibition imposed by DSIF/NELF in vitro. On the other hand, FACT 
is able to inhibit transcription in a minimal system reconstituted with only TBP, TFIIB, 
RNAPII and supercoiled DNA template containing the adenovirus major late promoter and 
a 350 bp G-less cassette (Wada et al., 2000). These studies suggest that FACT can activate 
or repress transcription in vitro through some mechanism. Drosophila polytene 
chromosome staining of FACT and hyperphosphorylated Pol II showed the two factors co-
localize and are redistributed to heat shock genes upon thermal induction (Saunders et 
al., 2003). Consistent with my evidence that the occupancies of Drosophila FACT and Pol II 
are correlated, yeast FACT has been reported to travel with Pol II on highly transcribed 
genes (Mason and Struhl, 2003). In cells deficient of FACT, the levels of the pre-initiation 
complex (TBP and TFIIB) were reduced at some genes (Mason and Struhl, 2003) 
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suggesting that not only does FACT regulate transcription elongation but also plays a role 
in regulating transcription initiation in vivo. In higher eukaryotes, the synthesis of mRNA 
by RNA polymerase is a highly regulated process. Firstly, transcription regulation occurs at 
the early stages where polymerase together with general transcription factors assemble 
into the pre-initiation complex at promoters. Secondly, regulation occurs at the early 
stages of elongation, 30-60 nucleotides downstream of the transcription start site, which 
is popularly termed promoter proximal pausing. Finally, RNA polymerase regulation 
occurs after polymerase enters an elongation phase after it escapes pausing checkpoints. 
Genome-wide studies have shown that promoter proximal pausing of RNA polymerase is 
a common and one of the key regulatory steps in the transcription of many 
developmental genes (Adelman and Lis, 2012; Kwak and Lis, 2013). Protein factors like 
DSIF and NELF have been shown to play a crucial role in maintaining RNA polymerase II at 
paused regions. Both proteins were shown in vitro to inhibit elongation and to co-occupy 
at paused regions (Wu et al., 2003; Yamaguchi et al., 2013). It was further shown that, 
depletion of these factors alleviates pausing in vivo. Promoter proximal pausing decisions 
can also be influenced by the core promoter elements (Kwak et al., 2013; Li and Gilmour, 
2013) and the +1 nucleosome (Kwak et al., 2013; Li and Gilmour, 2013; Weber et al., 
2014). In order for RNA Pol II to escape the promoter proximal region, the kinase P-TEFb 
comprising of Cyclin T1 and CDK9 phosphorylates DSIF, NELF and the CTD Ser2 of the Pol 
II subunit Rpb1 to relieve the Pol II of the inhibition (Peterlin and Price, 2006). Once RNA 
Pol II reaches elongation phase, the rate of elongation can be affected by different, not 
necessarily mutually exclusive factors. Some DNA sequences may be more difficult to 
transcribe than others owing to their DNA topology.  Histone marks can tighten or loosen 
DNA binding around nucleosomes, restricting or facilitating Pol II transcription efficiency. 
Elongation factors, histone chaperones and nucleosome remodelers can facilitate RNA Pol 
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II movement through chromatin by alleviating pausing and stalling during elongation, 
either by altering properties of elongating Pol II or of chromatin architecture (Jonkers and 
Lis, 2015). 
The role of FACT in regulating transcription initiation and elongation is not well 
understood in higher eukaryotes where transcription programs are complex. In this 
chapter, we provide evidence that is consistent with the role of FACT in promoter 
proximal pausing. 
4.2 Materials and Methods 
4.2.1 Chromatin Immunoprecipitation of Rpb3 
4.2.1.1 Cell culture, dsRNA mediated knockdown of FACT and western blot 
ChIP of Rpb3 was performed on Drosophila S2 cells depleted of FACT subunits as 
described above. 
4.2.1.2 Formaldehyde crosslinking, sonication and immunoprecipitation 
Formaldehyde crosslinking and sonication were carried out as described above 
using 10 µg of anti-Rpb3 (W. Shao and J. Zeitlinger) antibody coupled to Dynabeads® 
protein G (life technologies, 10004D).  
4.2.1.3 DNA purification 
The reverse crosslinked ChIP DNA was purified using Phenol:Chloroform:Isoamyl 
Alcohol as described above. 
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4.2.1.4 Library preparation and DNA sequencing 
The Molecular Biology Core of the Stowers Institute prepared libraries from the 
ChIPed DNA using the KAPA HTP kit (Kapa Biosystems), sized selected using the SPRIselect 
double side size selection kit (Beckman Coulter) and performed DNA sequencing on the 
Illumina HiSeq platform. 
4.2.1.5 ChIP-seq analysis 
The ~30million reads from each experiment was aligned using bowtie 2 to the 
drosophila dm6 genome as described above. 
4.2.2 PRO-seq (precision nuclear run-on and nuclear) 
4.2.2.1 Cell culture, dsRNA mediated knockdown of FACT and western blot 
In order to study the role of the FACT complex on transcriptionally engaged 
polymerases, I performed a PRO-seq on Drosophila S2 cells depleted of FACT subunit, 
SSRP1. For each replica, about 12×106 cells were seeded in a 100 mm dish and incubated 
at 25°C for 30 min to allow cells to attach to the bottom of the plate. Cells were then 
treated by adding 60 µg dsRNA to each dish and incubated for 48 hours at 25 degrees 
Celsius. A second dose of 60 µg dsRNA/dish was added and the cells harvested after 48 
hours to study the loss of function phenotypes. Cells were harvested and washed once in 
10 ml 1X PBS by centrifugation at 1000 x g for 4min in a swinging bucket at 4°C. A western 




4.2.2.2 Nuclear isolation for PRO-seq 
PRO-seq procedure and library preparation were performed exactly as previously 
described (Kwak and Lis, 2013; Mahat et al., 2016). Briefly, nuclei were isolated from the 
washed cells by resuspending gently in 5ml ice cold douncing buffer (10 mM Tris-HCl pH 
7.4, 300 mM sucrose, 3 mM CaCl2, 2 mM MgCl2, 0.1% Triton X-100, 0.5 mM DTT, 1 tablet 
of protease inhibitors cocktail (Roche 11873580001) per 50ml, 4 u/ml RNase inhibitor 
(SUPERaseIN, Ambion AM2696), incubated on ice for 5 min and dounced until 90% of cells 
were lysed (from 5-25) in a 5ml capacity Dounce homogenizer. Nuclei were then pelleted 
at 1000 x g for 4 min in a swinging bucket at 4°C, washed twice using 10 ml douncing 
buffer and resuspended in storage buffer (10 mM Tris-HCl pH 8.0, 25% (vol/vol) glycerol, 
5 mM MgAcetate 0.1 mM EDTA, 5 mM DTT) at a concentration of 20x106 nuclei/100 µl. 
The isolated nuclei in storage buffer were flash frozen in liquid nitrogen and stored at -
80°C. 
4.2.2.3 4-biotin nuclear run-on and PRO-seq library preparation 
To perform the 4-biotin run-on assay, 20x106 nuclei in 100 µl storage buffer were 
mixed thoroughly with an equal volume of preheated (30°C) 2X Nuclear Run-On master 
mix (10 mM Tris HCl pH 8.0, 5 mM MgCl2, 300 mM KCl, 1 mM DTT, 0.8 u/µl RNAse 
inhibitor (Ambion, AM2696), 1 % Sarkosyl and 50 µM each of all 4 biotin-NTPs 
(PerkinElmer Biotin-11-ATP, NEL544001EA; Biotin-11-GTP, NEL545001EA; Biotin-11-CTP 
NEL542001EA: Biotin-11-UTP NEL543001EA) and incubated for 3 min at 30°C in a heat 
block. The nascent RNA was extracted using Trizol LS (Invitrogen, 10296-028) and 
precipitated using 2.5 volumes of 100% ethanol. The purified RNA was resuspended in 20 
µl DEPC water, heat denatured at 65°C for 40 s and placed on ice. Denatured RNA 
samples were then fragmented by adding 5 µl of 1N NaOH and incubated on ice for 10 
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min, and neutralized by adding an equal volume of 1 M Tris-HCl pH 6.8. Excess salt and 
residual NTPs were then removed by passing base-hydrolyzed RNA samples through the 
P-30 column (Bio-Rad, 732-6250). In order to protect RNA samples from degradation, 1 µl 
RNase inhibitor (Life Technologies, AM2696) was added to each sample. Prior to enriching 
RNAs for biotinylated transcripts, 90 µl of streptavidin-coated magnetic beads (Life 
Technologies, 11206D) per library were washed once in 100 µl of buffer containing 0.1 N 
NaOH and 50 mM NaCl in DEPC water, and twice using 100 mM NaCl in DEPC water. 
Beads were finally resuspended in 150 µl binding buffer and divided into 3 aliquots. 
Biotinylated RNA transcripts were then enriched by binding fragmented RNAs to pre-
washed streptavidin M280 beads (Invitrogen, 11206D). Briefly, about 50 µl of RNA 
samples were bound to 50 µl pre-washed Streptavidin beads and incubated for 20 min at 
room temperature on a rotator. Bead-bound RNA samples were then washed twice in 
500 µl ice-cold high salt wash buffer (2 M NaCl, 50 mM Tris-HCl pH 7.4, 0.5% Triton X-
100), twice in 500 µl binding buffer (300 mM NaCl, 10 mM Tris-HCl pH 7.4, 0.1 % Triton X-
100), and once in 500 µl low salt buffer (5 mM Tris-HCl pH 7.4, 0.1% Triton X-100). Finally, 
RNAs were extracted from the beads using Trizol (Invitrogen, 15596-018) and ethanol 
precipitation. In order to ligate the 3’ RNA adaptor (5Phos/rGrArU rCrGrU rCrGrG rArCrU 
rGrUrA rGrArA rCrUrC rUrGrA rArC/3Inverted dT; IDT custom synthesis, RNase-free HPLC 
purified) to the fragmented RNAs, RNAs were resuspended in 4 µl 3’ RNA adaptor dilution 
(0.5 µl of 100 µM 3’ RNA adaptor in 3.5 µl of DEPC water), heat denatured at 65 °C for 20 
s and placed on ice. Denatured RNA samples were mixed with 6 µl RNA ligation mix (1 X 
T4 RNA ligase buffer, 1 mM ATP, 10 % PEG, 4 u/µl RNase inhibitor and 1 u/µl T4 RNA 
ligase I NEB, M0204S) and incubated at 20 °C for 4 h. To remove excess adaptors and salts 
from the ligated RNA, second biotin enrichments were performed using streptavidin 
beads as described above. RNAs were then purified from streptavidin beads using Trizol 
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and ethanol precipitation. Prior to ligating the reverse 5’ RNA adaptor (rCrCrU rUrGrG 
rCrArC rCrCrG rArGrA rArUrU rCrCrA, Custom synthesis from IDT, RNase-free HPLC 
purified) to the RNA, RNA pellets were resuspended in 5 µl DEPC water, heat denatured 
briefly at 65 °C for 20 s and placed on ice. Heat-denatured short nascent RNAs were then 
de-capped by mixing with 5 µl 5’cap repair enzyme mix (1X ThermoPol Reaction Buffer, 2 
u/µl RNase inhibitor, 0.5 u/µl RNA 5’ pyrophosphohydrolase, RppH, NEB, M0356S) and 
incubating at 37°C for 1 h. Next, the decapped RNAs were mixed with 90 µl PNK mix (1 X 
PNK buffer, 1 mM ATP, 1 u/µl RNase inhibitor and 0.25 u/µl T4 Polynucleotide Kinase 
NEB, M0201S) and incubated at 37°C for 1h. The 5’end modified RNAs were then purified 
using Trizol LS (Invitrogen, 10296-028) followed by ethanol precipitation. To perform the 
5’ adaptor ligation, RNAs were dissolved in 4 µl of 5’ RNA adaptor dilution (0.5 µl of 100 
µM 3’ RNA adaptor in 3.5 µl of DEPC water), heat-denatured at 65°C for 20 s and placed 
on ice. RNAs were then mixed with 6 µl RNA ligation mix (1 X T4 RNA ligase buffer, 1 mM 
ATP, 10 % PEG, 4 u/µl RNase inhibitor and 1 u/µl T4 RNA ligase I NEB, M0204S) and 
incubated at 20°C for 4 h. The cloned RNA products were then subjected to another 
round of biotin enrichment and purification using Trizol followed by ethanol precipitation 
and resuspended in 10 µl of DEPC water. To reverse transcribe the cloned products, RNAs 
were mixed with 2.5 µl RT primer mix (2.5 µM RP1 primer (AAT GAT ACG GCG ACC ACC 
GAG ATC TAC ACG TTC AGA GTT CTA CAG TCC GA, Custom synthesis from IDT, RNase-free 
HPLC purified), 625 µM dNTP mix) and incubated at 72°C for 2 min and chilled on ice for 2 
min. 6 µl of RT buffer mix (1 X First strand buffer, 5 mM DTT, 2 u/µl RNase inhibitor) was 
added to each RNA-primer mix and incubated at 37°C for 5 min. 1.5 µl Superscript III 
reverse transcriptase (Invitrogen, 56575) were mixed with the RNAs and incubated for 15 
min at 45 °C, then 40 min at 50 °C, 10 min at 55 °C and 15 min at 70 °C. Finally, 6 µl of 
DEPC water was added to the RT reaction. 
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An aliquot of the 26 µl cDNA from each replicate was used to carry out trial 
amplifications to determine the optimal number of cycles in order to avoid over 
amplification of the library. Four-fold serial dilutions (2 µl cDNA + 6 µl water) of cDNA 
were prepared using 2 µl cDNA aliquot from each experiment. Trial PCRs were carried out 
by mixing 1 µl of each serially diluted cDNA samples with 14 µl PCR mix (1 X HF buffer, 1 
M betaine, 250 µM each dNTP mix, 250 nM RP1 primer, 250 nM of either RPI4, RPI5, RPI6, 
or RPI7, and 0.02 u/µl Phusion DNA polymerase, NEB, M0530S) and running samples on 
the Eppendorf Mastercycler epgradient S using the following thermal conditions: 95 °C for 
2 min, 5 cycles of 95 °C, 56°C, 72 °C each for 30 s, 18 cycles of 95 °C, 65 °C, 72 °C each for 
30 s, followed by 72°C for 10 min, and stored at 4°C. Primers RPI4 (RNA PCR Primer Index 
4, CAA GCA GAA GAC GGC ATA CGA GAT TGG TCA GTG ACT GGA GTT CCT TGG CAC CCG 
AGA ATT CCA, Custom synthesis from IDT, RNase-free HPLC purified), RPI5 (RNA PCR 
Primer Index 5, CAA GCA GAA GAC GGC ATA CGA GAT CAC TGT GTG ACT GGA GTT CCT 
TGG CAC CCG AGA ATT CCA, Custom synthesis from IDT, RNase-free HPLC purified), RPI6 
(RNA PCR Primer Index 6 CAA GCA GAA GAC GGC ATA CGA GAT ATT GGC GTG ACT GGA 
GTT CCT TGG CAC CCG AGA ATT CCA, Custom synthesis from IDT, RNase-free HPLC 
purified) and RPI7 (RNA PCR Primer Index 7, CAA GCA GAA GAC GGC ATA CGA GAT GAT 
CTG GTG ACT GGA GTT CCT TGG CAC CCG AGA ATT CCA, Custom synthesis from IDT, 
RNase-free HPLC purified) were used to barcode cDNAs from NS1 (Non-targeting control, 
replicate 1), NS2 (Non-targeting control, replicate 2), SSRP1kda1 (SSRP1 dsRNA mediated 
knockdown, replicate 1), and SSRP1kda2 (SSRP1 dsRNA mediated knockdown, replicate 2) 
respectively. PCR amplicons from trial amplification were run on the Bioanalyser to 
determine the dilution with the optimum conditions (sufficient amount of product, not 
over amplified and having 50-75% of unused primers). Final full-scale PCR amplifications 
were carried out by mixing the remaining 24 µl cDNA samples with 0.5 µl RPI-n (25 µM) 
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primer, 25.5 µl full scale primer mix (1 X HF buffer, 1 M Betaine, 250 µM each dNTP mix, 
250 nM RP1 primer, 0.04 u/µl Phusion DNA polymerase), and running samples on the 
Eppendorf Mastercycler epgradient S using the following thermal conditions: 95 °C for 2 
min, 5 cycles of 95 °C, 56°C, 72 °C each for 30 s, 13 cycles of 95 °C, 65 °C, 72 °C each for 30 
s, followed by 72°C for 10 min, and stored at 4°C. PCR products were purified using 
ethanol precipitation and resuspended in 18 µl of water. PCR amplicons running from 140 
bp to 350 bp were selected using the 2% Agarose Gel Cassette, Dye-Free (Sage Science, 
CDF2010, Cassette type: 2% DF Marker L) on the Pippen Prep™ (Sage Science, Software: 
v.5.8) instrument. Briefly, DNA samples were made up to 30 µl with 1 X TE (10 mM Tris, 1 
mM EDTA, pH 8.0) buffer and mixed thoroughly with 10 µl of loading solution/marker. 
Next, the Pippin Prep software was launched, and the 2% DF Marker L protocol selected. 
Internal standards options were selected, and size selection parameters were set to 140 
bp – 350 bp. Prior to running, the Pippen optics were calibrated by placing the calibration 
fixture onto the optical nest and pressing calibrate to launch the calibration window. 0.80 
was entered in the “Target I ph, mA” and the calibrate button was pressed. After the 
calibration was complete the exit button was pressed. Next, buffer levels in the 2% gel 
cassette wells were inspected. Gel cassette was placed into the optical nest and the white 
adhesive strip removed. Buffers in the elution modules were removed and replaced with 
40 µl of fresh electrophoresis buffer. Elution wells were then sealed with an adhesive 
tape strip. Prior to loading the library, sample wells were filled to the top with buffer. A 
continuity test was performed to measure the current in each separation and elution 
channel. If everything goes well, a “PASS” should be returned for each separation and 
elution channel. To load DNA samples, 40 µl of buffer were removed from each well and 
40 µl of the prepared sample DNA loaded. To run, the “START” button was pressed on the 
main protocol tab. At the end of the run, samples were collected into 1.5 ml tubes and 
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quantified using the bioanalyzer. Equimolar concentrations of library fractions were 
pooled together and sequenced using a mid-output flow cell on the Illlumina NextSeq 
platform. 
4.2.2.4 PRO-seq bioinformatic analysis 
In all cases, we used the Dmel Release dm6 gene and transcript annotations 
downloaded from ensemble. The adapter sequences 5’-TGGAATTCTCGGGTGCCAAGG-3’ 
were removed from the reads and the reads trimmed to a maximum length of 36 bp. All 
reads less than 15 bp were filtered out, reverse-complemented and aligned with Bowtie2 
to dm6. RPKM were calculated as counts in each window per total mapped reads per 
length of the window. 
4.2.2.5 Active transcript identification 
In order to provide an overview of various genomic signatures for a given set of 
genes, we algorithmically assigned a specific “most active” transcript isoform to all known 
genes. To do this we used PRO-Seq promoter coverage, defined as -100 to +300 bp 
around all annotated transcription start sites (TSS), as a proxy for active transcripts. For 
each gene, the TSS from the site with the highest promoter coverage was kept for 
downstream analysis. 
4.2.2.6 Promoter pausing ratio (PPR) 
Pausing ratio was calculated as described (Kwak et al., 2013). Any genes that were 
less than 500 bp in length, overlapped other genes or were within 200 nt of nearby genes 
were excluded from the downstream analysis. The Pol II pause release ratio PRR was 
calculated by dividing the average gene body coverage (defined as +300 from the TSS to 
the end of the transcript) by the average promoter coverage (defined as -50 to +150 
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around the TSS). We also excluded genes with less than 1 RPKM PRO-seq signal in the 
promoter region in order to exclude non-active genes. In making this assumption we 
understand that in some cases greater coverage could be also be related to Pol II pausing 
and that alternative start sites within 100 nt of each other may result in confounding TSS 
selection. 
4.3 Results 
4.3.1 Loss of FACT leads to a decrease of Pol II at promoters of most genes and a 
subsequent increase gene bodies of a subset of genes 
Observations made thus far raise the possibility that FACT could play a role in 
regulating transcription initiation, elongation, or both. To investigate the role of FACT in 
regulating transcription initiation and elongation, I began by performing a ChIP-seq of 
Rpb3 in cells depleted of FACT and eGFP dsRNA treated cells to map RNA polymerase II 
independent of the phosphorylation state of the CTD. In addition, base-pair resolution of 
transcriptionally engaged polymerases were mapped, genome-wide, using the newly 
developed nuclear run-on assay called PRO-seq in Drosophila S2 cells depleted or not of 
FACT. An average gene plot of the distribution of ChIP signals of total RNA polymerase II 
(Rpb3 subunit) across the transcription start site (TSS) and the poly-adenylation site (pA) 
showed, as expected, an accumulation of Pol II at the TSS and a signal just higher than 
background across the transcribed regions in the non-targeting control S2 cells (Figure 
9A). We also observed that average gene plots of transcriptionally engaged RNA 
polymerase II (Figure 9B) measured using PRO-seq had very similar profile as the Pol II 
ChIP but with a base pair resolution. As shown in Figures 9A, 9B, 9C, and 9D RNAi-
mediated loss of FACT led to a decrease in Pol II accumulation at the TSS and an increase 
in RNA polymerase II signal across gene bodies of many non-overlapping genes (the 2023 
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genes included in the metagene analyses are longer than 0.5 kb, and have no overlapping 
genes or flanking genes within 200 bp to minimize ChIP signals associated with nearby 
genes). This observation suggests that FACT plays a role in regulating RNA polymerase II 
accumulation across transcribed regions. Our data are also consistent with the models 
that FACT is necessary for the proper loading of Pol II and/or helps to slow the transition 





Figure 9. FACT depletion alters distribution of transcriptionally engaged polymerases.  
(A) Metagene analysis showing Rpb3 enrichment by ChIP-seq over transcribed regions in 
Drosophila cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA (marked in blue), and 
Spt16 dsRNA (marked in green), aligned to the TSS and the TES. (B) Average PRO-seq profile over 
transcribed regions in Drosophila cells treated with eGFP dsRNA (marked in red), SSRP1 dsRNA 
(marked in blue) aligned to the TSS and the TES. (C) IGV genome browser snapshot comparing 
PRO-seq signals in cells treated with eGFP dsRNA (colored red) to cells treated with SSRP1 dsRNA 
(colored blue) within 18w (a highly paused gene), Hsp22 (locus highly bound by FACT), and Hsp26 
(locus highly bound by FACT) loci. Top right panel showing a rescaled version to emphasize 
changes in signal in the gene body. (D) Heatmap showing fold changes in PRO-seq and Rpb3 
signals in cells depleted of either subunit of FACT as indicated above. Brightest blue represents a 
fold decrease of 64 while the brightest red a fold increase of 64 
The 2023 non-overlapping genes included in the metagene analysis are active (have normalized 
promoter PRO-seq signal greater than 1 RPKM), longer than 0.5 kb and have no neighboring 




4.3.2 Potential role of FACT in promoter proximal pausing 
The 5’ accumulation of RNA polymerase II genome-wide in eukaryotes has 
previously been reported as evidence for promoter proximal pausing (Gariglio et al., 
1981; Rougvie and Lis, 1990; Wade and Struhl, 2008). The widely held view in the field is 
that promoter proximal pausing is a key rate limiting step in transcription elongation that 
can be caused by cis-regulatory elements and transacting factors. Thus, our observation 
that loss of FACT results in the decrease of promoter proximal Pol II signal led us to ask 
whether FACT plays a role in pausing. To address that, we calculated pausing indices using 
data from PRO-seq, which has some advantages over the ChIP-seq of Pol II. Advantages of 
using PRO-seq over ChIP-seq of Pol II are that (i) PRO-seq provides base-pair resolution, 
(ii) it provides strandedness information, and (iii) it measures only transcriptionally 
engaged polymerases. We then calculated the pausing index (Kwak et al., 2013), which is 
the ratio of Pol II signal in the promoter proximal region (from 50 bp upstream the TSS to 
150 bp downstream the TSS) versus the gene body (from 300 bp downstream the TSS to 
the polyadenylation site) (Figure 10A). We then classified the non-overlapping genes 
(N=2023) into highly paused (pausing index ≥ 23.5; n = 674 genes) moderately paused (3.3 
< pausing index < 23.5; n = 674 genes) and lowly paused (pausing index ≤ 3.3; n = 674) 
based on their pausing indices (Figures 10A and 10B). A metaplot of the distribution of 
total and transcriptionally engaged polymerases showed a high, medium and low 
promoter proximal signal in the highly, moderately and lowly paused categories 
respectively (Figure 10B). We then calculated the pause release ratio (Chen et al., 2015a) 
which is the inverse of our pausing index. Next, we calculated the paused release ratio 
fold change (PRR_FC) after FACT knockdown to explore the effect of loss of FACT on 
highly, moderately and lowly paused genes. A boxplot analysis of the paused release ratio 
fold change in the three pausing categories show greater increases in pause-release ratio 
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in more highly paused genes (Figure 10C). This data suggest that the loss of FACT has 
strongest effects on genes that are highly paused genes. In addition, the increase in 
promoter proximal release fold change among highly paused genes following loss of FACT 
is consistent with an increase in the rate of escape of promoter proximal Pol II and 
increase in distribution of Pol II in gene bodies  
4.3.3 Loss of FACT leads to increased RNA transcript abundance of highly paused 
genes 
Release from promoter proximal pausing is believed to be a rate limiting step in 
the transcription of many genes. If the observed increase in PRR at paused genes indeed 
reflects an increase in the rate with which Pol II is released into productive elongation, we 
might expect that FACT knockdown would lead to an increase in the abundance of mature 
transcripts at genes that exhibit the greatest changes in PRR.  To investigate this 
possibility, we performed a boxplot analysis of RNA transcript abundance fold change in 
the 3 pausing groups defined above (Figure 10D). Consistent with previous findings, t 
highly paused genes have relatively lower transcript abundance compared to moderately 
and lowly paused genes. in addition, following SSRP1 knockdown, we observed a 
significant increase (p< 1.78 x 10-11) in steady state RNA transcript abundance among the 







Figure 10. Highly paused genes are the most sensitive to the loss of FACT.  
(A) Schematic representation of the pausing index formula. Panel on the right showing 
distribution of pausing indices across eGFP dsRNA treated (indicated as NS1 and NS2) and 
SSRP1 (indicated as SSRP1kda1 and SSRP1kda2) deficient S2 cells. (B) Metagene analyses 
showing transcriptionally engaged RNA polymerase II (PRO-seq) across genes with varying 
degrees of pausing in eGFP dsRNA treated (marked red) and SSRP1 dsRNA treated 
(marked in blue) cells, aligned to the TSS and the TES. The non-overlapping genes 
included metagene analyses are active (have normalized promoter PRO-seq signal greater 
than 1 RPKM), longer than 0.5 kb and have no neighboring genes within 200 bp to reduce 
signals associated with nearby genes. Shaded area represents 95% confidence interval. 
(C) Boxplot analysis of pause release ratio log2 fold change following SSRP1 knockdown 
across genes with varying degrees of pausing. (D) Boxplots analysis showing log2 fold 
change in RNA transcript abundance following SSRP1 knockdown across genes with 
varying degrees of pausing.   
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4.3.4 Knockdown of FACT has stronger effects on H2Av, H3K4me3 and H3K36me3 on 
low paused genes than highly paused genes 
Based on observations thus far, I hypothesized that the degree to which the 
modified histones or the chromatin architecture can be reorganized (disassembled and 
/or reassembled) by FACT would be dependent on the level of pausing of the gene. To 
test this hypothesis, we performed metagene analyses of H3, MNase, H2Av, H3K4me3, 
H3K36me3 and H3K56ac across genes with varying degrees of pausing (highly paused 
genes, moderately paused genes and lowly paused genes) in eGFP dsRNA treated and 
FACT depleted cells (Figure 11-12).  
Results of this analysis indicate that lowly paused genes have higher nucleosome 
occupancy than highly paused genes (Figure 11A), consistent with observations made by 
the Adelman lab (Gilchrist et al., 2010). The loss of either subunit of FACT had no major 
change on H3 or H3K56ac occupancy on either highly paused or lowly paused genes 
(Figure 12C).  Also, consistent with previous observation, nucleosomes on lowly paused 
genes tend to be in an ordered state compared to highly paused genes. Again, the loss of 
either subunit of FACT has no major change in MNase-seq profiles on either highly paused 
or lowly paused genes (Figure 11B). 
Occupancy of the histone variant H2Av and of the modified histones H3K4me3 
and H3K36me3 was greatest on genes that exhibit low pausing and highest on the high 
pausing genes.  The loss of FACT, and in particular of its SSRP1 subunit, led to more 
substantial decreases in H2Av occupancy at low and moderately paused genes, but had 
minimal effect on H2Av occupancy at highly paused genes (Figure 11C). In addition, FACT 
dependent loss or 5’ ->3’shift in H3K4me3 and H3K36me3 were greatest among genes 






Figure 11. The loss of FACT has minimal effects on nucleosome occupancy, nucleosome 
positioning and H2Av independent of the pausing status of genes.  
Metagene analysis showing (A) H3 ChIP, (B) Nucleosome positioning measured by MNase-
seq, (C) H2Av over transcribed regions in Drosophila cells treated with eGFP dsRNA 
(marked in red), SSRP1 dsRNA (marked in blue), Spt16 dsRNA (marked green), aligned to 
the TSS and the TES. The 2023 non-overlapping genes included in each metagene analyses 
are active (have normalized promoter PRO-seq signal greater than 1 RPKM), longer than 
0.5 kb and have no neighboring genes within 200 bp to reduce signals associated with 






Figure 12. FACT depletion affects H3K4me3 and H3K36me3 with minimal effects on 
H3K56ac across genes with varying degrees of pausing.  
Metagene analysis showing (A) H3K4me3, (B) H3K36me3 (C) H2Av enrichment by ChIP-
seq over transcribed regions in Drosophila cells treated with eGFP dsRNA (marked in red), 
SSRP1 dsRNA (marked in blue), Spt16 dsRNA (marked green), aligned to the TSS and the 
TES. The 2023 non-overlapping genes included in each metagene analyses are active 
(have normalized promoter PRO-seq signal greater than 1 RPKM), longer than 0.5 kb and 
have no neighboring genes within 200 bp to reduce signals associated with nearby genes. 





The contribution of FACT in regulating the interplay between transcription and 
histone modification is not well understood in higher eukaryotes where transcription 
programs are complex. In this chapter, I provide data consistent with a role of FACT in 
promoter proximal pausing.  
Using high-throughput methods, we observed that the depletion of FACT leads to 
significant reduction of transcriptionally engaged RNA polymerase II around promoters, 
accompanied by an increase in transcriptionally engaged Pol II in gene bodies of a number 
of genes. Of note, highly paused genes exhibited the greatest dependence on FACT since 
we observed the greatest change in pause release ratio fold change among this class of 
genes. The observed FACT dependent increase in Pol II in gene bodies could be due to an 
increase in the rate of escape of Pol II from promoter locations to gene bodies.  
Consistent with this possibility, the FACT-dependent increase in pause release ratio fold 
change of highly paused genes is associated with an increase in RNA transcript 
abundance.  
Finally, I hypothesized that the degree to which modified histones, or the 
chromatin architecture can be reorganized (disassembled and /or reassembled) by FACT 
would be dependent on the level of pausing of the gene. Our preliminary results suggest 
that FACT dependent changes in H3K36me3, H3K4me3 and H2Av are greatest on genes 





The histone chaperone, FACT was previously characterized in vitro as a factor that 
stimulates transcription elongation over chromatinized templates by perhaps displacing 
H2A-H2B (Belotserkovskaya et al., 2003; Orphanides et al., 1998). Taking a genome-wide 
approach we observed that not only is FACT necessary to maintain the chromatin 
landscape during transcription but also plays a significant role in regulating the interplay 
between promoter proximal Pol II pausing and transcription-coupled histone 
modifications in higher eukaryotes. 
Promoter proximal pausing is now widely accepted as a regulatory step in the 
transcription of majority of active genes of eukaryotes (Jonkers and Lis, 2015). The role of 
FACT in regulating transcription initiation and elongation is not well understood in higher 
eukaryotes where transcription programs are complex. Based on the initial identification 
of FACT as an activity that enhances the ability of Pol II to elongate through nucleosomes 
on chromatin templates, I anticipated that FACT loss might make elongation, including 
the escape from promoter proximal pausing, less efficient. Data we have provided are 
indeed consistent with a role of FACT in regulating the efficiency with which Pol II can 
escape from promoter proximal pausing; however, and somewhat surprisingly, taken 
together the data presented in this thesis is most consistent with the idea that FACT 
depletion leads to an increase in the rate of Pol II release from promoter-proximal 
pausing. Using PRO-seq, we observed that the depletion of FACT leads to a reduction of 
transcriptionally engaged Pol II around promoters, accompanied by an increase in Pol II in 
gene bodies of many genes. Overall, the depletion of Drosophila FACT led to an increase 
in pause release ratio fold change, with the class of highly paused genes recording the 
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biggest increase. Since paused release ratio is a metric indicative of productive elongation 
(Chen et al., 2015a), we predicted an increase in differential gene expression for highly 
paused genes in the FACT depleted cells. Consistent with our prediction, we observed a 
significant increase in steady state RNA-seq among highly paused genes compared to 
moderately or lowly-paused genes (Figure 10D) following the depletion of SSRP1. These 
results suggest that the loss of FACT leads to an increase in productive elongation, 
occurring more frequently among highly paused genes. 
Several factors may explain the possible involvement of FACT in maintaining 
promoter proximal pausing. Firstly, FACT-dependent changes in nucleosome occupancy 
or positioning may influence the efficiency of promoter proximal pausing. Our data 
suggests that depleting FACT subunits in S2 cells leads to small but reproducible loss of 
nucleosomes. It is conceivable that depletion of promoter proximal nucleosome(s) during 
repeated rounds of transcription of a gene could remove a nucleosomal block to pause 
release. If this is true, we might expect to be able to detect changes in nucleosome 
dynamics following FACT depletion using a more sensitive method known as “CATCH-IT” 
(covalent attachment of tags to capture histones and identify turnover) which involves 
the pulse labeling of newly synthesized histones and the subsequent purification of newly 
assembled nucleosomes (Teves et al., 2012). 
Secondly, FACT-dependent changes in pause inducing (DSIF and NELF) or relieving 
(PTEFb) factors could modulate promoter proximal pausing efficiency. DSIF and NELF have 
been shown to play a crucial role in maintaining RNA polymerase II at paused regions (Wu 
et al., 2003; Yamaguchi et al., 2013). In order for RNA Pol II to escape the promoter 
proximal region, the kinase P-TEFb comprising of Cyclin T1 and CDK9 phosphorylates DSIF, 
NELF and the CTD Ser2 of the Pol II subunit Rpb1 to relieve the Pol II of the inhibition 
(Peterlin and Price, 2006). In addition, depletion of NELF and DSIF has been demonstrated 
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to alleviate pausing in vivo. If indeed FACT influences promoter proximal pausing by 
modulating pause inducing and relieving factors, it would be evident after performing 
ChIP-seq experiments of DSIF, NELF, PTEFb and Pol II ser2P in FACT depleted cells. 
 Finally, FACT has been reported to interact physically and functionally with 
transcription initiation and elongation modulators including Spt4/5 (Krogan et al., 2002; 
Squazzo et al., 2002) and the PAF complex- a protein complex implicated in promoter 
proximal pausing (Chen et al., 2015a; Yu et al., 2015). Notably, loss of PAF leads to 
increased pause-release coupled with increased CTD phosphorylation. Also, our data 
suggest that depleting FACT leads to increased pause release. Therefore, since FACT 
interacts with PAF, and depleting either PAF or FACT leads to increase in pause release, it 
is tempting to speculate that FACT might by an unknown mechanism modulate PAF 
function. If this is the case, one might predict that FACT depletion, like PAF depletion, 
might lead to changes in Ser2 phosphorylation and recruitment of Spt4/5, PAFc, P-TEFb or 
CDK12, ELL or other SEC components.  
The transcription unit is marked by H3K4me3 at 5’ ends (Barski et al., 2007; 
Schneider et al., 2004) and H3K36me3 within gene bodies (Wagner and Carpenter, 2012). 
Pol II CTD Ser5-P and Ser2-P contribute to the positioning of H3K4me3 and H3K36me3 
respectively, since the Set1 H3K4 methyl transferase interacts with Ser5-P Pol II CTD (Ng 
et al., 2003) and the SET2 H3K36 methyl transferases interacts with Pol II CTD Ser2-P 
(Kizer et al., 2005; Sun et al., 2005). Several lines of evidence suggest that changes in the 
rate of elongation, and hence the length of time Pol II spends in a particular region of the 
transcription unit, can affect the distribution of transcription-coupled modifications. 
Similarly, patterns of H3K4 methylation are sensitive to elongation rate in yeast, being 
shifted in a 5’ direction in cells expressing slowly elongating Pol II mutants, and in a 3’ 
direction in cells expressing fast Pol II mutants  (Soares et al., 2017).  Based on these 
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observations, it has been proposed that the position of these marks can be altered by the 
length of time that H3K4 or H3K36 methyltransferases associated with Pol II 
phosphorylated on Ser5 or Ser2 of the Rpb1 CTD, respectively, spend at different regions 
of the transcription unit during multiple rounds of transcription (Fong et al., 2017; Soares 





Figure 13. FACT contributes to the interplay between promoter proximal pausing 
regulation and transcription-coupled histone modifications.  
In control cells (top panel), under normal Pol II transcription rates, histone modifications 
are co-transcriptionally deposited, where H3K4me3 occupies 5' ends and H3K36me3 
occupies gene bodies. Upon depletion of FACT (bottom panel), Pol II moves quickly into 
productive elongation from paused sites through the relevant regions, elongation 
complex-associated methyltransferases would be allowed less time to place marks at any 
given place along the transcript, leading to the 5' to 3' shift in histone modifications 




Therefore, our observation that H3K4me3 shifted 5’ to 3’ in the FACT deficient 
cells made us to speculate that the broadening of H3K4me3 may be associated with 
transcription elongation. In light of these observations it is tempting to speculate that 
decreased H3K4 methylation in the promoter-proximal regions of genes could be a 
consequence of reduced of promoter-proximally paused Pol II.  Similarly, although we 
have not measured directly elongation rate throughout gene body in FACT-depleted cells, 
it is tempting to speculate that the relative loss of H3K4 trimethylation within promoters 
could be due to increased elongation rate due to FACT loss.  To address this possibility in 
the future it would be of interest to perform measurements of Pol II elongation rates 
throughout the gene body.  Such measurements can be made by treating cells with the 
initiation inhibitor triptolide or the P-TEFb inhibitor flavopiridol and following movement 
of Pol II along the template using techniques such as PRO-Seq, which measures the 
position of transcriptionally engaged Pol II. 
H3K36me3, the co-transcriptionally modified histone, marks transcribed regions 
and correlates with transcriptional activity (Pokholok et al., 2005). Results from our 
experiments demonstrate that depletion of subunits of FACT leads to global changes in 
H3K36me3 in the transcribed region and a surprising increase beyond the poly-A+ site of 
many genes exemplified by 18w and Inos (Figure 7B). Since the changes in global H3 
levels and micrococcal nuclease patterns were minimal in the FACT depleted cells, we 
could rule out the possibility that the massive changes in H3K36me3 is due to changes in 
bulk H3 patterns. 
Our findings suggest that H3K36 tri-methylation may depend on subunits of the 
FACT complex since the depletion of FACT led to global changes in H3K36me3. However, 
since the human H3K36 methyltransferase SETD2 activity is reported to modulate FACT 
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recruitment in human cell (Carvalho et al., 2013), we propose that FACT and H3K36me3 
and/or Set2 may have interdependent functions.  
In addition, we noted that the co-transcriptionally modified histone H3K36me3 
shifted 5’ to 3’ in the FACT depleted cells. It would be interesting to ask whether the 
FACT-dependent increase downstream of the Poly-A+ site is due to mislocalization and/ 
or changes in activities of set2 (H3K36me3 methyltransferase) and /or dKDM4A (a specific 
H3K36me3 demethylase).  Toward this end, I have raised antibodies against this 
methyltransferase and demethylase, and these can be used in ChIP assays. 
The shifts of histone modifications from 5’ to 3’ following the depletion of FACT is 
consistent with a direct role of FACT in proper localization of these marks. Alternatively, 
given that H3K4- and H3K36 methyltransferases interact with transcribing Pol II, it is not 
inconceivable that the 5’ to 3’ shifts in H3K4me3 and H3K36me3 could be as a result of 
changes in the distribution of Pol II across genes, perhaps due to differences in overall 
elongation rate or in the rate of escape of promoter proximally paused Pol II into more 3' 
regions of genes. 
In summary, our results taken together favor the model (Figure 13) that FACT 
plays a critical role in maintaining promoter proximal pausing. Thus, depletion of FACT 
leads to increase in the rate of escape of Pol II from paused sites thereby shifting co-








Reference List  
 
Adelman, K., and Lis, J.T. (2012). Promoter-proximal pausing of RNA polymerase II: 
emerging roles in metazoans. Nat. Rev. Genet 13, 720-731. 
Allfrey, V.G., FAULKNER, R., and Mirsky, A.E. (1964). ACETYLATION AND METHYLATION OF 
HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS. Proc. Natl. 
Acad. Sci. U. S. A 51, 786-794. 
Antosz, W., Pfab, A., Ehrnsberger, H.F., Holzinger, P., Kollen, K., Mortensen, S.A., 
Bruckmann, A., Schubert, T., Langst, G., Griesenbeck, J., et al. (2017). The Composition of 
the Arabidopsis RNA Polymerase II Transcript Elongation Complex Reveals the Interplay 
between Elongation and mRNA Processing Factors. Plant Cell 29, 854-870. 
Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., 
and Zhao, K. (2007). High-resolution profiling of histone methylations in the human 
genome. Cell 129, 823-837. 
Belotserkovskaya, R., Oh, S., Bondarenko, V.A., Orphanides, G., Studitsky, V.M., and 
Reinberg, D. (2003). FACT facilitates transcription-dependent nucleosome alteration. 
Science 301, 1090-1093. 
Biswas, D., Yu, Y., Prall, M., Formosa, T., and Stillman, D.J. (2005). The yeast FACT complex 
has a role in transcriptional initiation. Mol. Cell Biol 25, 5812-5822. 
Black, J.C., Van, R.C., and Whetstine, J.R. (2012). Histone lysine methylation dynamics: 
establishment, regulation, and biological impact. Mol. Cell 48, 491-507. 
Blanchette, M., Green, R.E., Brenner, S.E., and Rio, D.C. (2005). Global analysis of positive 
and negative pre-mRNA splicing regulators in Drosophila. Genes Dev. 19, 1306-1314. 
Blanchette, M., Green, R.E., MacArthur, S., Brooks, A.N., Brenner, S.E., Eisen, M.B., and 
Rio, D.C. (2009). Genome-wide analysis of alternative pre-mRNA splicing and RNA-binding 
specificities of the Drosophila hnRNP A/B family members. Mol. Cell 33, 438-449. 
Bonisch, C., and Hake, S.B. (2012). Histone H2A variants in nucleosomes and chromatin: 
more or less stable? Nucleic Acids Res. 40, 10719-10741. 
Brewster, N.K., Johnston, G.C., and Singer, R.A. (1998). Characterization of the CP 
complex, an abundant dimer of Cdc68 and Pob3 proteins that regulates yeast 
transcriptional activation and chromatin repression. J. Biol. Chem 273, 21972-21979. 
Brewster, N.K., Johnston, G.C., and Singer, R.A. (2001). A bipartite yeast SSRP1 analog 




Briggs, S.D., Bryk, M., Strahl, B.D., Cheung, W.L., Davie, J.K., Dent, S.Y., Winston, F., and 
Allis, C.D. (2001). Histone H3 lysine 4 methylation is mediated by Set1 and required for 
cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev. 15, 3286-3295. 
Bruce, K., Myers, F.A., Mantouvalou, E., Lefevre, P., Greaves, I., Bonifer, C., Tremethick, 
D.J., Thorne, A.W., and Crane-Robinson, C. (2005). The replacement histone H2A.Z in a 
hyperacetylated form is a feature of active genes in the chicken. Nucleic Acids Res. 33, 
5633-5639. 
Bruhn, S.L., Pil, P.M., Essigmann, J.M., Housman, D.E., and Lippard, S.J. (1992). Isolation 
and characterization of human cDNA clones encoding a high mobility group box protein 
that recognizes structural distortions to DNA caused by binding of the anticancer agent 
cisplatin. Proc. Natl. Acad. Sci. U. S. A 89, 2307-2311. 
Burgess, R.J., and Zhang, Z. (2013). Histone chaperones in nucleosome assembly and 
human disease. Nat. Struct. Mol. Biol 20, 14-22. 
Carrozza, M.J., Li, B., Florens, L., Suganuma, T., Swanson, S.K., Lee, K.K., Shia, W.J., 
Anderson, S., Yates, J., Washburn, M.P., and Workman, J.L. (2005). Histone H3 
methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress 
spurious intragenic transcription. Cell 123, 581-592. 
Carvalho, S., Raposo, A.C., Martins, F.B., Grosso, A.R., Sridhara, S.C., Rino, J., Carmo-
Fonseca, M., and de Almeida, S.F. (2013). Histone methyltransferase SETD2 coordinates 
FACT recruitment with nucleosome dynamics during transcription. Nucleic Acids Res. 41, 
2881-2893. 
Celic, I., Masumoto, H., Griffith, W.P., Meluh, P., Cotter, R.J., Boeke, J.D., and Verreault, A. 
(2006). The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 
lysine 56 deacetylation. Curr. Biol 16, 1280-1289. 
Chen, F.X., Woodfin, A.R., Gardini, A., Rickels, R.A., Marshall, S.A., Smith, E.R., Shiekhattar, 
R., and Shilatifard, A. (2015a). PAF1, a Molecular Regulator of Promoter-Proximal Pausing 
by RNA Polymerase II. Cell 162, 1003-1015. 
Chen, K., Chen, Z., Wu, D., Zhang, L., Lin, X., Su, J., Rodriguez, B., Xi, Y., Xia, Z., Chen, X., et 
al. (2015b). Broad H3K4me3 is associated with increased transcription elongation and 
enhancer activity at tumor-suppressor genes. Nat. Genet 47, 1149-1157. 
Clark-Adams, C.D., Norris, D., Osley, M.A., Fassler, J.S., and Winston, F. (1988). Changes in 
histone gene dosage alter transcription in yeast. Genes Dev. 2, 150-159. 
Clemens, J.C., Worby, C.A., Simonson-Leff, N., Muda, M., Maehama, T., Hemmings, B.A., 
and Dixon, J.E. (2000). Use of double-stranded RNA interference in Drosophila cell lines to 
dissect signal transduction pathways. Proc. Natl. Acad. Sci. U. S. A 97, 6499-6503. 
Das, C., Lucia, M.S., Hansen, K.C., and Tyler, J.K. (2009). CBP/p300-mediated acetylation of 
histone H3 on lysine 56. Nature 459, 113-117. 
Di Bussolo, V., and Minutolo, F. (2011). Curaxins: a new family of non-genotoxic 
multitargeted anticancer agents. ChemMedChem 6, 2133-2136. 
89 
 
Ding, Q., He, K., Luo, T., Deng, Y., Wang, H., Liu, H., Zhang, J., Chen, K., Xiao, J., Duan, X., et 
al. (2016). SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is 
Negatively Regulated by miR-497. Mol. Ther 24, 903-914. 
Finch, J.T., Lutter, L.C., Rhodes, D., Brown, R.S., Rushton, B., Levitt, M., and Klug, A. (1977). 
Structure of nucleosome core particles of chromatin. Nature 269, 29-36. 
Fong, N., Saldi, T., Sheridan, R.M., Cortazar, M.A., and Bentley, D.L. (2017). RNA Pol II 
Dynamics Modulate Co-transcriptional Chromatin Modification, CTD Phosphorylation, and 
Transcriptional Direction. Mol. Cell 66, 546-557 e543. 
Formosa, T., Eriksson, P., Wittmeyer, J., Ginn, J., Yu, Y., and Stillman, D.J. (2001). Spt16-
Pob3 and the HMG protein Nhp6 combine to form the nucleosome-binding factor SPN. 
EMBO J. 20, 3506-3517. 
Garcia, H., Fleyshman, D., Kolesnikova, K., Safina, A., Commane, M., Paszkiewicz, G., 
Omelian, A., Morrison, C., and Gurova, K. (2011). Expression of FACT in mammalian 
tissues suggests its role in maintaining of undifferentiated state of cells. Oncotarget 2, 
783-796. 
Garcia, H., Miecznikowski, J.C., Safina, A., Commane, M., Ruusulehto, A., Kilpinen, S., 
Leach, R.W., Attwood, K., Li, Y., Degan, S., et al. (2013). Facilitates chromatin transcription 
complex is an "accelerator" of tumor transformation and potential marker and target of 
aggressive cancers. Cell Rep 4, 159-173. 
Gariglio, P., Bellard, M., and Chambon, P. (1981). Clustering of RNA polymerase B 
molecules in the 5' moiety of the adult beta-globin gene of hen erythrocytes. Nucleic 
Acids Res. 9, 2589-2598. 
Gasparian, A.V., Burkhart, C.A., Purmal, A.A., Brodsky, L., Pal, M., Saranadasa, M., Bosykh, 
D.A., Commane, M., Guryanova, O.A., Pal, S., et al. (2011). Curaxins: anticancer 
compounds that simultaneously suppress NF-kappaB and activate p53 by targeting FACT. 
Sci. Transl. Med 3, 95ra74. 
Gilchrist, D.A., Dos, S.G., Fargo, D.C., Xie, B., Gao, Y., Li, L., and Adelman, K. (2010). 
Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable 
precise gene regulation. Cell 143, 540-551. 
Gilchrist, D.A., Nechaev, S., Lee, C., Ghosh, S.K., Collins, J.B., Li, L., Gilmour, D.S., and 
Adelman, K. (2008). NELF-mediated stalling of Pol II can enhance gene expression by 
blocking promoter-proximal nucleosome assembly. Genes Dev. 22, 1921-1933. 
Guillemette, B., Bataille, A.R., Gevry, N., Adam, M., Blanchette, M., Robert, F., and 
Gaudreau, L. (2005). Variant histone H2A.Z is globally localized to the promoters of 
inactive yeast genes and regulates nucleosome positioning. PLoS. Biol 3, e384. 
Han, J., Zhou, H., Horazdovsky, B., Zhang, K., Xu, R.M., and Zhang, Z. (2007). Rtt109 
acetylates histone H3 lysine 56 and functions in DNA replication. Science 315, 653-655. 
Hewish, D.R., and Burgoyne, L.A. (1973). Chromatin sub-structure. The digestion of 
chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. Biochem. 
Biophys. Res. Commun 52, 504-510. 
90 
 
Hondele, M., Stuwe, T., Hassler, M., Halbach, F., Bowman, A., Zhang, E.T., Nijmeijer, B., 
Kotthoff, C., Rybin, V., Amlacher, S., et al. (2013). Structural basis of histone H2A-H2B 
recognition by the essential chaperone FACT. Nature 499, 111-114. 
Hudson, M.E., Pozdnyakova, I., Haines, K., Mor, G., and Snyder, M. (2007). Identification 
of differentially expressed proteins in ovarian cancer using high-density protein 
microarrays. Proc. Natl. Acad. Sci. U. S. A 104, 17494-17499. 
Ikeda, Y., Kinoshita, Y., Susaki, D., Ikeda, Y., Iwano, M., Takayama, S., Higashiyama, T., 
Kakutani, T., and Kinoshita, T. (2011). HMG domain containing SSRP1 is required for DNA 
demethylation and genomic imprinting in Arabidopsis. Dev. Cell 21, 589-596. 
Iouzalen, N., Moreau, J., and Mechali, M. (1996). H2A.ZI, a new variant histone expressed 
during Xenopus early development exhibits several distinct features from the core 
histone H2A. Nucleic Acids Res. 24, 3947-3952. 
Jackson, J.D., Falciano, V.T., and Gorovsky, M.A. (1996). A likely histone H2A.F/Z variant in 
Saccharomyces cerevisiae. Trends Biochem. Sci 21, 466-467. 
Jackson, J.D., and Gorovsky, M.A. (2000). Histone H2A.Z has a conserved function that is 
distinct from that of the major H2A sequence variants. Nucleic Acids Res. 28, 3811-3816. 
Jeronimo, C., Watanabe, S., Kaplan, C.D., Peterson, C.L., and Robert, F. (2015). The 
Histone Chaperones FACT and Spt6 Restrict H2A.Z from Intragenic Locations. Mol. Cell 58, 
1113-1123. 
John, S., Howe, L., Tafrov, S.T., Grant, P.A., Sternglanz, R., and Workman, J.L. (2000). The 
something about silencing protein, Sas3, is the catalytic subunit of NuA3, a yTAF(II)30-
containing HAT complex that interacts with the Spt16 subunit of the yeast CP 
(Cdc68/Pob3)-FACT complex. Genes Dev. 14, 1196-1208. 
Johns, E.W. (1967). The electrophoresis of histones in polyacrylamide gel and their 
quantitative determination. Biochem. J 104, 78-82. 
Jonkers, I., and Lis, J.T. (2015). Getting up to speed with transcription elongation by RNA 
polymerase II. Nat. Rev. Mol. Cell Biol 16, 167-177. 
Kaplan, C.D., Laprade, L., and Winston, F. (2003). Transcription elongation factors repress 
transcription initiation from cryptic sites. Science 301, 1096-1099. 
Keller, D.M., and Lu, H. (2002). p53 serine 392 phosphorylation increases after UV 
through induction of the assembly of the CK2.hSPT16.SSRP1 complex. J. Biol. Chem 277, 
50206-50213. 
Kemble, D.J., McCullough, L.L., Whitby, F.G., Formosa, T., and Hill, C.P. (2015). FACT 
Disrupts Nucleosome Structure by Binding H2A-H2B with Conserved Peptide Motifs. Mol. 
Cell 60, 294-306. 
Kemble, D.J., Whitby, F.G., Robinson, H., McCullough, L.L., Formosa, T., and Hill, C.P. 
(2013). Structure of the Spt16 middle domain reveals functional features of the histone 
chaperone FACT. J. Biol. Chem 288, 10188-10194. 
91 
 
Kizer, K.O., Phatnani, H.P., Shibata, Y., Hall, H., Greenleaf, A.L., and Strahl, B.D. (2005). A 
novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 
methylation with transcript elongation. Mol. Cell. Biol. 25, 3305-3316. 
Koman, I.E., Commane, M., Paszkiewicz, G., Hoonjan, B., Pal, S., Safina, A., Toshkov, I., 
Purmal, A.A., Wang, D., Liu, S., et al. (2012). Targeting FACT complex suppresses 
mammary tumorigenesis in Her2/neu transgenic mice. Cancer Prev. Res. (Phila) 5, 1025-
1035. 
Kornberg, R.D. (1974). Chromatin structure: a repeating unit of histones and DNA. Science 
184, 868-871. 
Kornberg, R.D., and Thomas, J.O. (1974). Chromatin structure; oligomers of the histones. 
Science 184, 865-868. 
Krogan, N.J., Keogh, M.C., Datta, N., Sawa, C., Ryan, O.W., Ding, H., Haw, R.A., Pootoolal, 
J., Tong, A., Canadien, V., et al. (2003). A Snf2 family ATPase complex required for 
recruitment of the histone H2A variant Htz1. Mol. Cell 12, 1565-1576. 
Krogan, N.J., Kim, M., Ahn, S.H., Zhong, G., Kobor, M.S., Cagney, G., Emili, A., Shilatifard, 
A., Buratowski, S., and Greenblatt, J.F. (2002). RNA polymerase II elongation factors of 
Saccharomyces cerevisiae: a targeted proteomics approach. Mol. Cell Biol 22, 6979-6992. 
Kusch, T., Florens, L., Macdonald, W.H., Swanson, S.K., Glaser, R.L., Yates, J.R., III, Abmayr, 
S.M., Washburn, M.P., and Workman, J.L. (2004). Acetylation by Tip60 is required for 
selective histone variant exchange at DNA lesions. Science 306, 2084-2087. 
Kwak, H., Fuda, N.J., Core, L.J., and Lis, J.T. (2013). Precise maps of RNA polymerase reveal 
how promoters direct initiation and pausing. Science 339, 950-953. 
Kwak, H., and Lis, J.T. (2013). Control of transcriptional elongation. Annu. Rev. Genet 47, 
483-508. 
Kwon, S.H., Florens, L., Swanson, S.K., Washburn, M.P., Abmayr, S.M., and Workman, J.L. 
(2010). Heterochromatin protein 1 (HP1) connects the FACT histone chaperone complex 
to the phosphorylated CTD of RNA polymerase II. Genes Dev. 24, 2133-2145. 
Laskey, R.A., Honda, B.M., Mills, A.D., and Finch, J.T. (1978). Nucleosomes are assembled 
by an acidic protein which binds histones and transfers them to DNA. Nature 275, 416-
420. 
Laskey, R.A., Mills, A.D., and Morris, N.R. (1977). Assembly of SV40 chromatin in a cell-
free system from Xenopus eggs. Cell 10, 237-243. 
Latham, J.A., and Dent, S.Y. (2007). Cross-regulation of histone modifications. Nat. Struct. 
Mol. Biol 14, 1017-1024. 
Leach, T.J., Mazzeo, M., Chotkowski, H.L., Madigan, J.P., Wotring, M.G., and Glaser, R.L. 
(2000). Histone H2A.Z is widely but nonrandomly distributed in chromosomes of 
Drosophila melanogaster. J. Biol. Chem 275, 23267-23272. 
92 
 
Lee, T.I., Johnstone, S.E., and Young, R.A. (2006). Chromatin immunoprecipitation and 
microarray-based analysis of protein location. Nat. Protoc 1, 729-748. 
Li, J., and Gilmour, D.S. (2013). Distinct mechanisms of transcriptional pausing 
orchestrated by GAGA factor and M1BP, a novel transcription factor. EMBO J. 32, 1829-
1841. 
Li, J., Moazed, D., and Gygi, S.P. (2002). Association of the histone methyltransferase Set2 
with RNA polymerase II plays a role in transcription elongation. J. Biol. Chem 277, 49383-
49388. 
Li, Y., Zeng, S.X., Landais, I., and Lu, H. (2007). Human SSRP1 has Spt16-dependent and -
independent roles in gene transcription. J. Biol. Chem 282, 6936-6945. 
Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F., and Richmond, T.J. (1997). Crystal 
structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260. 
Maas, N.L., Miller, K.M., DeFazio, L.G., and Toczyski, D.P. (2006). Cell cycle and checkpoint 
regulation of histone H3 K56 acetylation by Hst3 and Hst4. Mol. Cell 23, 109-119. 
Mahat, D.B., Kwak, H., Booth, G.T., Jonkers, I.H., Danko, C.G., Patel, R.K., Waters, C.T., 
Munson, K., Core, L.J., and Lis, J.T. (2016). Base-pair-resolution genome-wide mapping of 
active RNA polymerases using precision nuclear run-on (PRO-seq). Nat. Protoc 11, 1455-
1476. 
Malone, E.A., Clark, C.D., Chiang, A., and Winston, F. (1991). Mutations in SPT16/CDC68 
suppress cis- and trans-acting mutations that affect promoter function in Saccharomyces 
cerevisiae. Mol. Cell Biol 11, 5710-5717. 
Mason, P.B., and Struhl, K. (2003). The FACT complex travels with elongating RNA 
polymerase II and is important for the fidelity of transcriptional initiation in vivo. Mol. Cell 
Biol 23, 8323-8333. 
Masse, J.E., Wong, B., Yen, Y.M., Allain, F.H., Johnson, R.C., and Feigon, J. (2002). The S. 
cerevisiae architectural HMGB protein NHP6A complexed with DNA: DNA and protein 
conformational changes upon binding. J. Mol. Biol 323, 263-284. 
Masumoto, H., Hawke, D., Kobayashi, R., and Verreault, A. (2005). A role for cell-cycle-
regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature 436, 294-
298. 
Mizuguchi, G., Shen, X., Landry, J., Wu, W.H., Sen, S., and Wu, C. (2004). ATP-driven 
exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. 
Science 303, 343-348. 
Ng, H.H., Robert, F., Young, R.A., and Struhl, K. (2003). Targeted recruitment of Set1 
histone methylase by elongating Pol II provides a localized mark and memory of recent 
transcriptional activity. Mol. Cell 11, 709-719. 
Noma, K., and Grewal, S.I. (2002). Histone H3 lysine 4 methylation is mediated by Set1 
and promotes maintenance of active chromatin states in fission yeast. Proceedings of the 
National Academy of Sciences of the United States of America 99 Suppl 4, 16438-16445. 
93 
 
O'Donnell, A.F., Brewster, N.K., Kurniawan, J., Minard, L.V., Johnston, G.C., and Singer, 
R.A. (2004). Domain organization of the yeast histone chaperone FACT: the conserved N-
terminal domain of FACT subunit Spt16 mediates recovery from replication stress. Nucleic 
Acids Res. 32, 5894-5906. 
Okuhara, K., Ohta, K., Seo, H., Shioda, M., Yamada, T., Tanaka, Y., Dohmae, N., Seyama, Y., 
Shibata, T., and Murofushi, H. (1999). A DNA unwinding factor involved in DNA replication 
in cell-free extracts of Xenopus eggs. Curr. Biol 9, 341-350. 
Olins, A.L., and Olins, D.E. (1974). Spheroid chromatin units (v bodies). Science 183, 330-
332. 
Orphanides, G., LeRoy, G., Chang, C.H., Luse, D.S., and Reinberg, D. (1998). FACT, a factor 
that facilitates transcript elongation through nucleosomes. Cell 92, 105-116. 
Orphanides, G., Wu, W.H., Lane, W.S., Hampsey, M., and Reinberg, D. (1999). The 
chromatin-specific transcription elongation factor FACT comprises human SPT16 and 
SSRP1 proteins. Nature 400, 284-288. 
Oudet, P., Gross-Bellard, M., and Chambon, P. (1975). Electron microscopic and 
biochemical evidence that chromatin structure is a repeating unit. Cell 4, 281-300. 
Ozdemir, A., Spicuglia, S., Lasonder, E., Vermeulen, M., Campsteijn, C., Stunnenberg, H.G., 
and Logie, C. (2005). Characterization of lysine 56 of histone H3 as an acetylation site in 
Saccharomyces cerevisiae. J. Biol. Chem 280, 25949-25952. 
Papamichos-Chronakis, M., Watanabe, S., Rando, O.J., and Peterson, C.L. (2011). Global 
regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is essential 
for genome integrity. Cell 144, 200-213. 
Peterlin, B.M., and Price, D.H. (2006). Controlling the elongation phase of transcription 
with P-TEFb. Mol. Cell 23, 297-305. 
Pokholok, D.K., Harbison, C.T., Levine, S., Cole, M., Hannett, N.M., Lee, T.I., Bell, G.W., 
Walker, K., Rolfe, P.A., Herbolsheimer, E., et al. (2005). Genome-wide map of nucleosome 
acetylation and methylation in yeast. Cell 122, 517-527. 
Powell, W., and Reines, D. (1996). Mutations in the second largest subunit of RNA 
polymerase II cause 6-azauracil sensitivity in yeast and increased transcriptional arrest in 
vitro. J. Biol. Chem 271, 6866-6873. 
Raisner, R.M., Hartley, P.D., Meneghini, M.D., Bao, M.Z., Liu, C.L., Schreiber, S.L., Rando, 
O.J., and Madhani, H.D. (2005). Histone variant H2A.Z marks the 5' ends of both active 
and inactive genes in euchromatin. Cell 123, 233-248. 
Ransom, M., Williams, S.K., Dechassa, M.L., Das, C., Linger, J., Adkins, M., Liu, C., 
Bartholomew, B., and Tyler, J.K. (2009). FACT and the proteasome promote promoter 
chromatin disassembly and transcriptional initiation. J. Biol. Chem 284, 23461-23471. 
Recht, J., Tsubota, T., Tanny, J.C., Diaz, R.L., Berger, J.M., Zhang, X., Garcia, B.A., 
Shabanowitz, J., Burlingame, A.L., Hunt, D.F., et al. (2006). Histone chaperone Asf1 is 
94 
 
required for histone H3 lysine 56 acetylation, a modification associated with S phase in 
mitosis and meiosis. Proc. Natl. Acad. Sci. U. S. A 103, 6988-6993. 
Richmond, T.J., and Davey, C.A. (2003). The structure of DNA in the nucleosome core. 
Nature 423, 145-150. 
Richmond, T.J., Finch, J.T., Rushton, B., Rhodes, D., and Klug, A. (1984). Structure of the 
nucleosome core particle at 7 A resolution. Nature 311, 532-537. 
Rougvie, A.E., and Lis, J.T. (1990). Postinitiation transcriptional control in Drosophila 
melanogaster. Mol. Cell Biol 10, 6041-6045. 
Rufiange, A., Jacques, P.E., Bhat, W., Robert, F., and Nourani, A. (2007). Genome-wide 
replication-independent histone H3 exchange occurs predominantly at promoters and 
implicates H3 K56 acetylation and Asf1. Mol. Cell 27, 393-405. 
Safina, A., Garcia, H., Commane, M., Guryanova, O., Degan, S., Kolesnikova, K., and 
Gurova, K.V. (2013). Complex mutual regulation of facilitates chromatin transcription 
(FACT) subunits on both mRNA and protein levels in human cells. Cell Cycle 12, 2423-
2434. 
Saunders, A., Werner, J., Andrulis, E.D., Nakayama, T., Hirose, S., Reinberg, D., and Lis, J.T. 
(2003). Tracking FACT and the RNA polymerase II elongation complex through chromatin 
in vivo. Science 301, 1094-1096. 
Schneider, R., Bannister, A.J., Myers, F.A., Thorne, A.W., Crane-Robinson, C., and 
Kouzarides, T. (2004). Histone H3 lysine 4 methylation patterns in higher eukaryotic 
genes. Nat. Cell Biol. 6, 73-77. 
Sevilla, A., and Binda, O. (2014). Post-translational modifications of the histone variant 
H2AZ. Stem Cell Res 12, 289-295. 
Shi, Y., and Whetstine, J.R. (2007). Dynamic regulation of histone lysine methylation by 
demethylases. Mol. Cell 25, 1-14. 
Shilatifard, A. (2012). The COMPASS family of histone H3K4 methylases: mechanisms of 
regulation in development and disease pathogenesis. Annu. Rev. Biochem 81, 65-95. 
Shimojima, T., Okada, M., Nakayama, T., Ueda, H., Okawa, K., Iwamatsu, A., Handa, H., 
and Hirose, S. (2003). Drosophila FACT contributes to Hox gene expression through 
physical and functional interactions with GAGA factor. Genes Dev. 17, 1605-1616. 
Soares, L.M., He, P.C., Chun, Y., Suh, H., Kim, T., and Buratowski, S. (2017). Determinants 
of Histone H3K4 Methylation Patterns. Mol. Cell 68, 773-785 e776. 
Squazzo, S.L., Costa, P.J., Lindstrom, D.L., Kumer, K.E., Simic, R., Jennings, J.L., Link, A.J., 
Arndt, K.M., and Hartzog, G.A. (2002). The Paf1 complex physically and functionally 
associates with transcription elongation factors in vivo. EMBO J. 21, 1764-1774. 
Stanlie, A., Aida, M., Muramatsu, M., Honjo, T., and Begum, N.A. (2010). Histone3 lysine4 
trimethylation regulated by the facilitates chromatin transcription complex is critical for 
95 
 
DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. U. S. A 107, 22190-
22195. 
Strahl, B.D., Grant, P.A., Briggs, S.D., Sun, Z.W., Bone, J.R., Caldwell, J.A., Mollah, S., Cook, 
R.G., Shabanowitz, J., Hunt, D.F., and Allis, C.D. (2002). Set2 is a nucleosomal histone H3-
selective methyltransferase that mediates transcriptional repression. Mol. Cell Biol 22, 
1298-1306. 
Stuwe, T., Hothorn, M., Lejeune, E., Rybin, V., Bortfeld, M., Scheffzek, K., and Ladurner, 
A.G. (2008). The FACT Spt16 "peptidase" domain is a histone H3-H4 binding module. Proc. 
Natl. Acad. Sci. U. S. A 105, 8884-8889. 
Sun, X.J., Wei, J., Wu, X.Y., Hu, M., Wang, L., Wang, H.H., Zhang, Q.H., Chen, S.J., Huang, 
Q.H., and Chen, Z. (2005). Identification and characterization of a novel human histone H3 
lysine 36-specific methyltransferase. J. Biol. Chem. 280, 35261-35271. 
Teves, S.S., Deal, R.B., and Henikoff, S. (2012). Measuring genome-wide nucleosome 
turnover using CATCH-IT. Methods Enzymol. 513, 169-184. 
Toney, J.H., Donahue, B.A., Kellett, P.J., Bruhn, S.L., Essigmann, J.M., and Lippard, S.J. 
(1989). Isolation of cDNAs encoding a human protein that binds selectively to DNA 
modified by the anticancer drug cis-diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. 
U. S. A 86, 8328-8332. 
Tsunaka, Y., Toga, J., Yamaguchi, H., Tate, S., Hirose, S., and Morikawa, K. (2009). 
Phosphorylated intrinsically disordered region of FACT masks its nucleosomal DNA 
binding elements. J. Biol. Chem 284, 24610-24621. 
VanDemark, A.P., Blanksma, M., Ferris, E., Heroux, A., Hill, C.P., and Formosa, T. (2006). 
The structure of the yFACT Pob3-M domain, its interaction with the DNA replication 
factor RPA, and a potential role in nucleosome deposition. Mol. Cell 22, 363-374. 
VanDemark, A.P., Xin, H., McCullough, L., Rawlins, R., Bentley, S., Heroux, A., Stillman, 
D.J., Hill, C.P., and Formosa, T. (2008). Structural and functional analysis of the Spt16p N-
terminal domain reveals overlapping roles of yFACT subunits. J. Biol. Chem 283, 5058-
5068. 
Wada, T., Orphanides, G., Hasegawa, J., Kim, D.K., Shima, D., Yamaguchi, Y., Fukuda, A., 
Hisatake, K., Oh, S., Reinberg, D., and Handa, H. (2000). FACT relieves DSIF/NELF-
mediated inhibition of transcriptional elongation and reveals functional differences 
between P-TEFb and TFIIH. Mol. Cell 5, 1067-1072. 
Wade, J.T., and Struhl, K. (2008). The transition from transcriptional initiation to 
elongation. Curr. Opin. Genet. Dev 18, 130-136. 
Wagner, E.J., and Carpenter, P.B. (2012). Understanding the language of Lys36 
methylation at histone H3. Nat. Rev. Mol. Cell Biol 13, 115-126. 
Weber, C.M., Ramachandran, S., and Henikoff, S. (2014). Nucleosomes are context-
specific, H2A.Z-modulated barriers to RNA polymerase. Mol. Cell 53, 819-830. 
96 
 
Wittmeyer, J., and Formosa, T. (1997). The Saccharomyces cerevisiae DNA polymerase 
alpha catalytic subunit interacts with Cdc68/Spt16 and with Pob3, a protein similar to an 
HMG1-like protein. Mol. Cell Biol 17, 4178-4190. 
Woodcock, C.L., Safer, J.P., and Stanchfield, J.E. (1976). Structural repeating units in 
chromatin. I. Evidence for their general occurrence. Exp. Cell Res 97, 101-110. 
Wu, C.H., Yamaguchi, Y., Benjamin, L.R., Horvat-Gordon, M., Washinsky, J., Enerly, E., 
Larsson, J., Lambertsson, A., Handa, H., and Gilmour, D. (2003). NELF and DSIF cause 
promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev. 17, 1402-
1414. 
Xiang, Y.Y., Wang, D.Y., Tanaka, M., Igarashi, H., Naito, Y., Ohtawara, Y., Shen, Q., and 
Sugimura, H. (1996). Expression of structure-specific recognition protein mRNA in fetal 
kidney and Fe-nitrilotriacetate-induced renal carcinoma in the rat. Cancer Lett. 106, 271-
278. 
Xin, H., Takahata, S., Blanksma, M., McCullough, L., Stillman, D.J., and Formosa, T. (2009). 
yFACT induces global accessibility of nucleosomal DNA without H2A-H2B displacement. 
Mol. Cell 35, 365-376. 
Yamaguchi, Y., Shibata, H., and Handa, H. (2013). Transcription elongation factors DSIF 
and NELF: promoter-proximal pausing and beyond. Biochim. Biophys. Acta 1829, 98-104. 
Yu, M., Yang, W., Ni, T., Tang, Z., Nakadai, T., Zhu, J., and Roeder, R.G. (2015). RNA 
polymerase II-associated factor 1 regulates the release and phosphorylation of paused 
RNA polymerase II. Science 350, 1383-1386. 
Yuan, J., Pu, M., Zhang, Z., and Lou, Z. (2009). Histone H3-K56 acetylation is important for 
genomic stability in mammals. Cell Cycle 8, 1747-1753. 
Zhang, H., Roberts, D.N., and Cairns, B.R. (2005). Genome-wide dynamics of Htz1, a 
histone H2A variant that poises repressed/basal promoters for activation through histone 
loss. Cell 123, 219-231. 
Zhang, W., Zeng, F., Liu, Y., Shao, C., Li, S., Lv, H., Shi, Y., Niu, L., Teng, M., and Li, X. (2015). 
Crystal Structure of Human SSRP1 Middle Domain Reveals a Role in DNA Binding. Sci. Rep 
5, 18688. 
 
